Menu
Back to Journals » OncoTargets and Therapy » Volume 9
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6490)
- Volume 17, 2024 (52)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 9, 2016
Non-secretory multiple myeloma: from biology to clinical management
Dupuis MM, Tuchman SA
OncoTargets and Therapy 2016, 9:7583-7590
Published Date: 15 December 2016
Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives
Mulet-Margalef N, Garcia-del-Muro X
OncoTargets and Therapy 2016, 9:7573-7582
Published Date: 15 December 2016
Lipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner
Cheng G, Yang S, Zhang G, Xu Y, Liu X, Sun W, Zhu L
OncoTargets and Therapy 2016, 9:7563-7571
Published Date: 14 December 2016
Evaluation of the efficacy of chemoradiotherapy in cervical cancer using diffusion-weighted imaging and apparent diffusion coefficient
Ju F
OncoTargets and Therapy 2016, 9:7555-7561
Published Date: 13 December 2016
Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role
Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E
OncoTargets and Therapy 2016, 9:7545-7553
Published Date: 13 December 2016
The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning
Zhu J, Simon A, Haigron P, Lafond C, Acosta O, Shu H, Castelli J, Li B, De Crevoisier R
OncoTargets and Therapy 2016, 9:7537-7544
Published Date: 12 December 2016
A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience
Ranieri G, Niccoli Asabella A, Altini C, Fazio V, Caporusso L, Marech I, Vinciarelli G, Macina F, de Ceglia D, Fanelli M, Ammendola M, Rubini G, Gadaleta CD
OncoTargets and Therapy 2016, 9:7527-7535
Published Date: 12 December 2016
β-Elemene treatment of glioblastoma: a single-center retrospective study
Ma C, Zhou W, Yan Z, Qu M, Bu X
OncoTargets and Therapy 2016, 9:7521-7526
Published Date: 12 December 2016
Correlation between epidermal growth factor receptor tyrosine kinase inhibitor efficacy and circulating tumor cell levels in patients with advanced non-small cell lung cancer
He W, Li W, Jiang B, Chang L, Jin C, Tu C, Li Y
OncoTargets and Therapy 2016, 9:7515-7520
Published Date: 12 December 2016
Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells
Souza e Silva V, Chinen LTD, Abdallah EA, Damascena A, Paludo J, Chojniak R, Dettino ALA, Mello CAL, Alves VS, Fanelli MF
OncoTargets and Therapy 2016, 9:7503-7513
Published Date: 13 December 2016
Overexpression and clinical significance of MYC-associated zinc finger protein in pancreatic carcinoma
Zhu X, Luo W, Liang W, Tang F, Bei C, Ren Y, Qin L, Tan C, Zhang Y, Tan S
OncoTargets and Therapy 2016, 9:7493-7501
Published Date: 12 December 2016
Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells
Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M
OncoTargets and Therapy 2016, 9:7481-7492
Published Date: 12 December 2016
Biomarkers in pancreatic adenocarcinoma: current perspectives
Swords DS, Firpo MA, Scaife CL, Mulvihill SJ
OncoTargets and Therapy 2016, 9:7459-7467
Published Date: 9 December 2016
Comprehensive profile of differentially expressed circular RNAs reveals that hsa_circ_0000069 is upregulated and promotes cell proliferation, migration, and invasion in colorectal cancer
Guo J, Li J, Zhu C, Feng W, Shao J, Wan L, Huang M, He J
OncoTargets and Therapy 2016, 9:7451-7458
Published Date: 9 December 2016
Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements
Ocal N, Yildiz B, Karadurmus N, Dogan D, Ozaydin S, Ocal R, Ozturk M, Arpaci F, Bilgic H
OncoTargets and Therapy 2016, 9:7445-7450
Published Date: 9 December 2016
Omega-3 polyunsaturated fatty acids in the prevention of postoperative complications in colorectal cancer: a meta-analysis
Xie H, Chang Y
OncoTargets and Therapy 2016, 9:7435-7443
Published Date: 9 December 2016
Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients
Wen X, Lu F, Liu S
OncoTargets and Therapy 2016, 9:7425-7433
Published Date: 8 December 2016
Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population
Yan WY, Hu J, Xie L, Cheng L, Yang M, Li L, Shi J, Liu BR, Qian X
OncoTargets and Therapy 2016, 9:7415-7424
Published Date: 8 December 2016
Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis
Shi H, Wang X, Wang J, Pan J, Liu J, Ye B
OncoTargets and Therapy 2016, 9:7409-7414
Published Date: 8 December 2016
Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data
Liu Y, Ni R, Zhang H, Miao L, Wang J, Jia W, Wang Y
OncoTargets and Therapy 2016, 9:7397-7407
Published Date: 7 December 2016
Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran
Dolatkhah R, Somi MH, Asvadi Kermani I, Bonyadi M, Sepehri B, Boostani K, Azadbakht S, Fotouhi N, Farassati F, Dastgiri S
OncoTargets and Therapy 2016, 9:7385-7395
Published Date: 7 December 2016
Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway
Kang Y, Hu W, Bai E, Zheng H, Liu Z, Wu J, Jin R, Zhao C, Liang G
OncoTargets and Therapy 2016, 9:7373-7384
Published Date: 5 December 2016
Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma
Peng L, Yang G, Wu C, Wang WS, Wu J, Guo Z
OncoTargets and Therapy 2016, 9:7367-7372
Published Date: 2 December 2016
Next-generation sequencing: advances and applications in cancer diagnosis
Serratì S, De Summa S, Pilato B, Petriella D, Lacalamita R, Tommasi S, Pinto R
OncoTargets and Therapy 2016, 9:7355-7365
Published Date: 2 December 2016
Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches
Lakhlili W, Yasri A, Ibrahimi A
OncoTargets and Therapy 2016, 9:7345-7353
Published Date: 2 December 2016
History and progression of Fat cadherins in health and disease
Zhang X, Liu J, Liang X, Chen J, Hong J, Li L, He Q, Cai X
OncoTargets and Therapy 2016, 9:7337-7343
Published Date: 1 December 2016
Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors
Yu H, Zhang LL, Du X, Sheng XG
OncoTargets and Therapy 2016, 9:7331-7335
Published Date: 1 December 2016
Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel
Khosravian P, Shafiee Ardestani M, Khoobi M, Ostad SN, Dorkoosh FA, Akbari Javar H, Amanlou M
OncoTargets and Therapy 2016, 9:7315-7330
Published Date: 1 December 2016
Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics
Smaletz O, Chacón M, de Oliveira Koch L, de Carvalho Rocha DR, Cardoso FC
OncoTargets and Therapy 2016, 9:7309-7314
Published Date: 30 November 2016
Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1
Zhang J, Fu J, Pan Y, Zhang X, Shen L
OncoTargets and Therapy 2016, 9:7297-7307
Published Date: 1 December 2016
CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer
Yang K, Gao K, Hu G, Wen Y, Lin C, Li X
OncoTargets and Therapy 2016, 9:7285-7295
Published Date: 30 November 2016
A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer
Garon EB, Neidhart JD, Gabrail NY, de Oliveira MR, Balkissoon J, Kabbinavar F
OncoTargets and Therapy 2016, 9:7275-7283
Published Date: 30 November 2016
Androgen deprivation therapy as backbone therapy in the management of prostate cancer
Merseburger AS, Alcaraz A, von Klot CA
OncoTargets and Therapy 2016, 9:7263-7274
Published Date: 29 November 2016
Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression
Xue F, Liu YH, Zhang HW, Wen Y, Yan L, Tang Q, Xiao EH, Zhang DY
OncoTargets and Therapy 2016, 9:7253-7261
Published Date: 28 November 2016
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma
Azzouqa AG, Stevenson JP
OncoTargets and Therapy 2016, 9:7247-7252
Published Date: 25 November 2016
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives
Davidson M, Starling N
OncoTargets and Therapy 2016, 9:7235-7245
Published Date: 25 November 2016
Comparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage Ⅲ non–small cell lung cancer
Kong M, Hong SE
OncoTargets and Therapy 2016, 9:7227-7234
Published Date: 24 November 2016
E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol
Hu YX, He HL, Lu J, Wang Y, Xiao PF, Li JQ, Li J, Sun YN, Lv H, Fan JJ, Yao YH, Chai YH, Hu SY
OncoTargets and Therapy 2016, 9:7219-7225
Published Date: 22 November 2016
Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time
Baek N, Seo OW, Kim M, Hulme J, An SSA
OncoTargets and Therapy 2016, 9:7207-7218
Published Date: 22 November 2016
High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma
Na N, Si T, Huang Z, Miao B, Hong L, Li H, Qiu J, Qiu J
OncoTargets and Therapy 2016, 9:7199-7205
Published Date: 22 November 2016
Effect of smoking on the genetic makeup of toll-like receptors 2 and 6
Kohailan M, Alanazi M, Rouabhia M, Alamri A, Parine NR, Alhadheq A, Basavarajappa S, Abdullah Al-Kheraif AA, Semlali A
OncoTargets and Therapy 2016, 9:7187-7198
Published Date: 21 November 2016
The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma
Wang J, Wang SZ, Song XM, Zeng WJ, Wang SY, Chen F, Ding H
OncoTargets and Therapy 2016, 9:7177-7185
Published Date: 21 November 2016
Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
Liang P, Huang C, Liang S, Li Y, Huang S, Lian Z, Liu J, Tang Y, Lu H
OncoTargets and Therapy 2016, 9:7169-7175
Published Date: 18 November 2016
Next-generation sequence detects ARAP3 as a novel oncogene in papillary thyroid carcinoma
Wang QX, Chen ED, Cai YF, Zhou YL, Zheng ZC, Wang YH, Jin YX, Jin WX, Zhang XH, Wang OC
OncoTargets and Therapy 2016, 9:7161-7167
Published Date: 18 November 2016
BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy
Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK
OncoTargets and Therapy 2016, 9:7149-7159
Published Date: 12 December 2016
Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
Wu F, Lu H, Zhu S, Li Z, Zou L, Bai T, Chen J, Yang T, Liang S
OncoTargets and Therapy 2016, 9:7141-7147
Published Date: 1 December 2016
Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference
Kim MG, Ko M, Kim IW, Oh JM
OncoTargets and Therapy 2016, 9:7133-7139
Published Date: 18 November 2016
Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Suzuki SO, Iwaki T, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2016, 9:7123-7131
Published Date: 17 November 2016
Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells
Xie L, Zhao T, Cai J, Su Y, Wang Z, Dong W
OncoTargets and Therapy 2016, 9:7115-7122
Published Date: 17 November 2016
Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases
Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, Xie TT, Li YQ, Peng ZG, Chen G
OncoTargets and Therapy 2016, 9:7105-7114
Published Date: 17 November 2016
A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation
Frithiof H, Aaltonen K, Ryden L
OncoTargets and Therapy 2016, 9:7095-7103
Published Date: 16 November 2016
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial
Harrington KJ, Andtbacka RHI, Collichio F, Downey G, Chen L, Szabo Z, Kaufman HL
OncoTargets and Therapy 2016, 9:7081-7093
Published Date: 16 November 2016
Lrig1 is a positive prognostic marker in hepatocellular carcinoma
Yang B, Dai C, Tan RM, Zhang B, Meng X, Ye J, Wang XQ, Wei L, He F, Chen ZS
OncoTargets and Therapy 2016, 9:7071-7079
Published Date: 15 November 2016
Meta-analysis of outcomes of patients with stage IV colorectal cancer managed with chemotherapy/radiochemotherapy with and without primary tumor resection
Lee KC, Ou YC, Hu WH, Liu CC, Chen HH
OncoTargets and Therapy 2016, 9:7059-7069
Published Date: 15 November 2016
MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1
Xu D, Chen XF, He QY, Luo CQ
OncoTargets and Therapy 2016, 9:7047-7057
Published Date: 15 November 2016
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
Yang F, Lv S, Lv L, Liu Y, Dong S, Yao Z, Dai X, Zhang X, Wang O
OncoTargets and Therapy 2016, 9:7039-7045
Published Date: 15 November 2016
Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma
Lin M, Tian MM, Zhang WP, Xu L, Jin P
OncoTargets and Therapy 2016, 9:7029-7037
Published Date: 14 November 2016
ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
Chen L, Liu MM, Liu H, Lu D, Zhao XD, Yang XJ
OncoTargets and Therapy 2016, 9:7019-7028
Published Date: 14 November 2016
CT-diagnosed severe skull base bone destruction predicts distant bone metastasis in early N-stage nasopharyngeal carcinoma
Yi W, Liu ZG, Li X, Tang J, Jiang CB, Hu JY, Tu ZW, Wang H, Niu DL, Xia YF
OncoTargets and Therapy 2016, 9:7011-7017
Published Date: 14 November 2016
MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1
Hu ZL, Cui YH, Zhou YH, Zhou KY, Qiao XQ, Li CQ, Wang S
OncoTargets and Therapy 2016, 9:6999-7009
Published Date: 14 November 2016
The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis
Zhai R, Tang F, Gong JH, Zhang J, Lei B, Li B, Wei YC, Liang XS, Tang B, He SQ
OncoTargets and Therapy 2016, 9:6987-6998
Published Date: 24 November 2016
Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis
Yang X, Yang L, Dai W, Ye B
OncoTargets and Therapy 2016, 9:6977-6985
Published Date: 11 November 2016
Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis
Su X, Jiang X, Wang W, Wang H, Xu X, Lin A, Teng X, Wu H, Teng L
OncoTargets and Therapy 2016, 9:6965-6976
Published Date: 11 November 2016
RETRACTED ARTICLE: Portulacerebroside A inhibits adhesion, migration, and invasion of human leukemia HL60 cells and U937 cells through the regulation of p38/JNK signaling pathway
Ye QD, Liao XL, Fu P, Dou JY, Chen K, Jiang H
OncoTargets and Therapy 2016, 9:6953-6963
Published Date: 11 November 2016
Comparison of internal target volumes defined on 3-dimensional, 4-dimensonal, and cone-beam CT images of non-small-cell lung cancer
Li F, Li J, Ma Z, Zhang Y, Xing J, Qi H, Shang D
OncoTargets and Therapy 2016, 9:6945-6951
Published Date: 17 November 2016
Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion
Chen B, Xia L, Xu C, Xiao F, Wang Y
OncoTargets and Therapy 2016, 9:6935-6943
Published Date: 9 November 2016
Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells
Pileczki V, Pop L, Braicu C, Budisan L, Bolba Morar G, del C Monroig-Bosque P, Sandulescu RV, Berindan-Neagoe I
OncoTargets and Therapy 2016, 9:6921-6933
Published Date: 11 November 2016
A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma
Zhao YY, Liu L, Zhou T, Zhou NN, Yang YP, Hou X, Li Y, Zhao HY, Huang Y, Zhang L
OncoTargets and Therapy 2016, 9:6915-6920
Published Date: 8 November 2016
miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial–mesenchymal transition
Zhang XG, Zhang T, Yang K, Zhang MH, Wang KM
OncoTargets and Therapy 2016, 9:6909-6914
Published Date: 8 November 2016
Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection
Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ
OncoTargets and Therapy 2016, 9:6897-6907
Published Date: 10 November 2016
Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer
Lee AR, Park J, Jung KJ, Jee SH, Kim-Yoon SJ
OncoTargets and Therapy 2016, 9:6885-6895
Published Date: 7 November 2016
Hürthle cell carcinoma: current perspectives
Ahmadi S, Stang M, Jiang XS, Sosa JA
OncoTargets and Therapy 2016, 9:6873-6884
Published Date: 7 November 2016
NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J, Xu Y, Zhang S, Liu X, Sun Q
OncoTargets and Therapy 2016, 9:6865-6871
Published Date: 7 November 2016
FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma
El-Hamamsy M, Ghali RR, Saad AS, Shaheen SM, Salem AM
OncoTargets and Therapy 2016, 9:6857-6863
Published Date: 7 November 2016
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma
Jeannot V, Busser B, Vanwonterghem L, Michallet S, Ferroudj S, Cokol M, Coll JL, Ozturk M, Hurbin A
OncoTargets and Therapy 2016, 9:6843-6855
Published Date: 9 November 2016
Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma
Xu Y, Guo Q, Lin J, Chen B, Wen J, Lu T, Xu Y, Zhang M, Pan J, Lin S
OncoTargets and Therapy 2016, 9:6835-6841
Published Date: 4 November 2016
Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management
Wu S, Mo M, Wang Y, Zhang N, Li J, Di G, Shao Z, Wu J, Liu G
OncoTargets and Therapy 2016, 9:6829-6834
Published Date: 4 November 2016
Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
Iovanescu D, Frandes M, Lungeanu D, Burlea A, Miutescu BP, Miutescu E
OncoTargets and Therapy 2016, 9:6819-6828
Published Date: 4 November 2016
Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography
Wang XF, Li KG, Sun HR, Zhao JL, Zheng LF, Zhang ZL, Bai RJ, Zhang GX
OncoTargets and Therapy 2016, 9:6809-6817
Published Date: 3 November 2016
Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis
Yang Y, Xiong Y, Li J, Wu C, Jiang J
OncoTargets and Therapy 2016, 9:6801-6808
Published Date: 3 November 2016
Total versus subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials
Kong L, Yang N, Shi L, Zhao G, Wang M, Zhang Y
OncoTargets and Therapy 2016, 9:6795-6800
Published Date: 7 November 2016
Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking
Coppola C, Riccio G, Barbieri A, Monti MG, Piscopo G, Rea D, Arra C, Maurea C, De Lorenzo C, Maurea N
OncoTargets and Therapy 2016, 9:6785-6794
Published Date: 2 November 2016
Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study
Luo Y, Ren J, Zhou P, Gao Y, Yang G, Lang J
OncoTargets and Therapy 2016, 9:6775-6783
Published Date: 1 November 2016
The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
Shen ZS, Zhou CC, Li JY, Deng HX, Li Q, Wang J
OncoTargets and Therapy 2016, 9:6763-6773
Published Date: 31 October 2016
Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis
Lv L, Hu WD, Ren YC, Wei XX
OncoTargets and Therapy 2016, 9:6751-6762
Published Date: 31 October 2016
Positive expression of KIF20A indicates poor prognosis of glioma patients
Duan J, Huang W, Shi H
OncoTargets and Therapy 2016, 9:6741-6749
Published Date: 2 November 2016
A current perspective on stereotactic body radiation therapy for pancreatic cancer
Hong JC, Czito BG, Willett CG, Palta M
OncoTargets and Therapy 2016, 9:6733-6739
Published Date: 31 October 2016
Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells
Zheng YP, Sun MM, Chen JY, He LL, Zhao N, Chen KS
OncoTargets and Therapy 2016, 9:6727-6732
Published Date: 31 October 2016
High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma
Zhang L, Xiu DR, Zhan J, He XK, Guo LM, Wang JL, Tao M, Fu W, Zhang HQ
OncoTargets and Therapy 2016, 9:6719-6726
Published Date: 31 October 2016
Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer
Gao H, Yao Q, Lan X, Li S, Wu J, Zeng G, Xue Y
OncoTargets and Therapy 2016, 9:6711-6718
Published Date: 31 October 2016
Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis
Chen Z, Shao Y, Wang K, Cao W, Xiong Y, Wu R, Luo S, Xu X, He X
OncoTargets and Therapy 2016, 9:6701-6710
Published Date: 28 October 2016
Efficacy and toxicities of adding molecular targeted agents to first-line chemotherapy in the treatment of advanced biliary tract cancer: a systematic review and meta-analysis
Zhao S, Miao Y, Wang R, Guo H, Jin F, Guo X, Luo T
OncoTargets and Therapy 2016, 9:6695-6700
Published Date: 28 October 2016
Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients
Kurtz JE, Soubeyran P, Michallet M, Luporsi E, Albrand H
OncoTargets and Therapy 2016, 9:6689-6693
Published Date: 28 October 2016
Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression
Yu N, Zhu H, Tao Y, Huang Y, Song X, Zhou Y, Li Y, Pei Q, Tan Q, Pei H
OncoTargets and Therapy 2016, 9:6679-6687
Published Date: 28 October 2016
Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis
Artene S, Turcu-Stiolica A, Hartley R, Ciurea ME, Daianu O, Brindusa C, Alexandru O, Tataranu LG, Purcaru SO, Dricu A
OncoTargets and Therapy 2016, 9:6669-6677
Published Date: 4 November 2016
SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
Komiya K, Nakamura T, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N
OncoTargets and Therapy 2016, 9:6663-6668
Published Date: 27 October 2016
The medicinal fungus Antrodia cinnamomea regulates DNA repair and enhances the radiosensitivity of human esophageal cancer cells
Liu YM, Liu YK, Wang LW, Huang YC, Huang PI, Tsai TH, Chen YJ
OncoTargets and Therapy 2016, 9:6651-6661
Published Date: 27 October 2016
Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects
Qiu H, Cheng C, Wang Y, Kang M, Tang W, Chen S, Gu H, Liu C, Chen Y
OncoTargets and Therapy 2016, 9:6641-6650
Published Date: 27 October 2016
MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis through interaction with β-catenin
Qiang R, Cai N, Wang X, Wang L, Cui K, Wang X, Li X
OncoTargets and Therapy 2016, 9:6631-6640
Published Date: 28 October 2016
BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer
Zhao H, Wang WL, Zhao QH, Hu GM, Deng KH, Liu YL
OncoTargets and Therapy 2016, 9:6619-6629
Published Date: 26 October 2016
Inhibitory effects of silibinin on proliferation and lung metastasis of human high metastasis cell line of salivary gland adenoid cystic carcinoma via autophagy induction
Jiang C, Jin S, Jiang Z, Wang J
OncoTargets and Therapy 2016, 9:6609-6618
Published Date: 26 October 2016
Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis
Ye CY, Wang J, Zheng S, Chai Y
OncoTargets and Therapy 2016, 9:6605-6608
Published Date: 26 October 2016
miR-497 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1
Zhang N, Shen Q, Zhang P
OncoTargets and Therapy 2016, 9:6597-6604
Published Date: 25 October 2016
The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer
Liu YY, Tu L, Wang L, Long J, Wang J, Wang Y, Luo F, Cao D
OncoTargets and Therapy 2016, 9:6581-6595
Published Date: 25 October 2016
Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease
Hua J, Ding T, Yang L
OncoTargets and Therapy 2016, 9:6573-6579
Published Date: 25 October 2016
Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
Cai CF, Sun JY, He Z, Lin HX, Liu FR, Wang Y
OncoTargets and Therapy 2016, 9:6569-6572
Published Date: 25 October 2016
Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia
Maklad AM, Bayoumi Y, Senosy Hassan MA, Elawadi AA, AlHussain H, Elyamany A, Aldhahri SF, Al-Qahtani KH, AlQahtani M, Tunio MA
OncoTargets and Therapy 2016, 9:6561-6567
Published Date: 25 October 2016
Cell-free DNA as a diagnostic marker for cancer: current insights
Salvi S, Gurioli G, De Giorgi U, Conteduca V, Tedaldi G, Calistri D, Casadio V
OncoTargets and Therapy 2016, 9:6549-6559
Published Date: 25 October 2016
WISP-1 overexpression upregulates cell proliferation in human salivary gland carcinomas via regulating MMP-2 expression
Li FJ, Wang XJ, Zhou XL
OncoTargets and Therapy 2016, 9:6539-6548
Published Date: 21 October 2016
The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer
Jin F, Han A, Shi F, Kong L, Yu J
OncoTargets and Therapy 2016, 9:6529-6537
Published Date: 21 October 2016
Novel therapeutic strategies for patients with triple-negative breast cancer
Zhang JF, Liu J, Wang Y, Zhang B
OncoTargets and Therapy 2016, 9:6519-6528
Published Date: 21 October 2016
High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells
Chen X, Zhang Q, Luo Y, Gao C, Zhuang X, Xu G, Qaio T
OncoTargets and Therapy 2016, 9:6511-6518
Published Date: 21 October 2016
The diagnostic value of 99TcM-2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl dihydrogen phosphate hypoxia imaging and its evaluation performance for radiotherapy efficacy in non-small-cell lung cancer
Yang Y, Han G, Xu W
OncoTargets and Therapy 2016, 9:6499-6509
Published Date: 21 October 2016
Snake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines
Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M
OncoTargets and Therapy 2016, 9:6485-6498
Published Date: 20 October 2016
The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China
Xu J, Ding G, Zhang X, Jin B, Lou Y, Zhang Y, Wang H, Wu D, Han B
OncoTargets and Therapy 2016, 9:6479-6484
Published Date: 20 October 2016
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer
Lorusso L, Pieruzzi L, Biagini A, Sabini E, Valerio L, Giani C, Passannanti P, Pontillo-Contillo B, Battaglia V, Mazzeo S, Molinaro E, Elisei R
OncoTargets and Therapy 2016, 9:6467-6477
Published Date: 20 October 2016
Dephosphorylated cofilin expression is associated with poor prognosis in cases of human breast cancer: a tissue microarray analysis
Maimaiti Y, Liu ZM, Tan J, Abudureyimu K, Huang BX, Liu CP, Guo YW, Wang CW, Nie X, Zhou J, Huang T
OncoTargets and Therapy 2016, 9:6461-6466
Published Date: 19 October 2016
Inhibitory effect of quercetin on epithelial to mesenchymal transition in SK-MEL-28 human melanoma cells defined by in vitro analysis on 3D collagen gels
Patel DH, Sharma N
OncoTargets and Therapy 2016, 9:6445-6459
Published Date: 19 October 2016
Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database
Lin MQ, Li YP, Wu SG, Sun JY, Lin HX, Zhang SY, He ZY
OncoTargets and Therapy 2016, 9:6435-6444
Published Date: 19 October 2016
Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
Mürtz P, Penner AH, Pfeiffer AK, Sprinkart AM, Pieper CC, König R, Block W, Schild HH, Willinek WA, Kukuk GM
OncoTargets and Therapy 2016, 9:6425-6433
Published Date: 19 October 2016
Prognostic nutritional index serves as a predicative marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2016, 9:6417-6423
Published Date: 19 October 2016
Double-edged role of G protein-coupled estrogen receptor 1 in breast cancer prognosis: an analysis of 167 breast cancer samples and online data sets
Yang F, Shao ZM
OncoTargets and Therapy 2016, 9:6407-6415
Published Date: 25 October 2016
Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma
He HT, Xu M, Kuang Y, Han XY, Wang MQ, Yang Q
OncoTargets and Therapy 2016, 9:6399-6406
Published Date: 18 October 2016
Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma
Sun P, Zhang F, Chen C, Ren C, Bi XW, Yang H, An X, Wang FH, Jiang WQ
OncoTargets and Therapy 2016, 9:6389-6397
Published Date: 17 October 2016
Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus
Wang S, Shu J, Chen L, Chen X, Zhao J, Li S, Mou X, Tong X
OncoTargets and Therapy 2016, 9:6381-6388
Published Date: 17 October 2016
miR-32 functions as a tumor suppressor and directly targets SOX9 in human non–small cell lung cancer [Retraction]
Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L
OncoTargets and Therapy 2016, 9:6379-6380
Published Date: 20 October 2016
MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction]
Lin FO, Yao LJ, Xiao J, Liu DF, Ni ZY
OncoTargets and Therapy 2016, 9:6377-6378
Published Date: 20 October 2016
Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice
Passaro A, Lazzari C, Karachaliou N, Spitaleri G, Pochesci A, Catania C, Rosell R, de Marinis F
OncoTargets and Therapy 2016, 9:6361-6376
Published Date: 17 October 2016
Cancer: fundamentals behind pH targeting and the double-edged approach
Koltai T
OncoTargets and Therapy 2016, 9:6343-6360
Published Date: 17 October 2016
Rare frequency of gene variation and survival analysis in thymic epithelial tumors
Song Z, Yu X, Zhang Y
OncoTargets and Therapy 2016, 9:6337-6342
Published Date: 14 October 2016
Alveolar rhabdomyosarcoma of the sphenoid sinus mimicking optic neuritis presenting with intermittent visual loss in an adult
Liu W, Jiang L, Jin Y, Yang BT, Lai TYY
OncoTargets and Therapy 2016, 9:6333-6336
Published Date: 14 October 2016
hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A
OncoTargets and Therapy 2016, 9:6325-6332
Published Date: 14 October 2016
18F-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients
Bai L, Guo CH, Wang JS, Liu X, Li Y, Li M, Guo YM, Duan XY
OncoTargets and Therapy 2016, 9:6315-6324
Published Date: 14 October 2016
Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience
Lin L, Zhao J, Hu J, Huang F, Han J, He Y, Cao X
OncoTargets and Therapy 2016, 9:6305-6314
Published Date: 14 October 2016
Prognostic value of endocan expression in cancers: evidence from meta-analysis
Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L
OncoTargets and Therapy 2016, 9:6297-6304
Published Date: 13 October 2016
Primary adenoid cystic carcinoma of the trachea with thyroid invasion: a case report and literature review
Qi D, Feng L, Li J, Liu B, Zhang Q
OncoTargets and Therapy 2016, 9:6291-6296
Published Date: 13 October 2016
Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation
Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR
OncoTargets and Therapy 2016, 9:6281-6290
Published Date: 13 October 2016
CT-detected solitary thyroid calcification: an important imaging feature for papillary carcinoma
Yang T, Huang Y, Jing X, Gai X, Li W
OncoTargets and Therapy 2016, 9:6273-6279
Published Date: 13 October 2016
Locally advanced rectal cancer: management challenges
Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J
OncoTargets and Therapy 2016, 9:6265-6272
Published Date: 13 October 2016
Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis
Song J, Shi W, Zhang Y, Sun M, Liang X, Zheng S
OncoTargets and Therapy 2016, 9:6257-6263
Published Date: 12 October 2016
miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process
Pan Y, Zhang J, Fu H, Shen L
OncoTargets and Therapy 2016, 9:6247-6255
Published Date: 11 October 2016
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
De Vita A, Mercatali L, Recine F, Pieri F, Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G, Amadori D, Ibrahim T
OncoTargets and Therapy 2016, 9:6233-6246
Published Date: 11 October 2016
Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma
Vicari L, La Rosa C, Forte S, Calabrese G, Colarossi C, Aiello E, Salluzzo S, Memeo L
OncoTargets and Therapy 2016, 9:6225-6231
Published Date: 11 October 2016
Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis
Yu H, Li H, Zhang J, Liu G
OncoTargets and Therapy 2016, 9:6211-6224
Published Date: 11 October 2016
miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer
He S, Zhang G, Dong H, Ma M, Sun Q
OncoTargets and Therapy 2016, 9:6203-6210
Published Date: 11 October 2016
Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells
Liu L, Wang ZH, Han J, Tang C, Chen N, Lin Z, Peng PJ
OncoTargets and Therapy 2016, 9:6195-6201
Published Date: 11 October 2016
Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
Zhu S, Miao CW, Wang ZT, Peng L, Li B
OncoTargets and Therapy 2016, 9:6187-6193
Published Date: 13 October 2016
Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation
Meng L, Xu Y, Xu C, Zhang W
OncoTargets and Therapy 2016, 9:6177-6185
Published Date: 11 October 2016
Invasive atypical thymic carcinoid: three case reports and literature review
Zhu S, Wang Z, Liu W, Zong S, Li B
OncoTargets and Therapy 2016, 9:6171-6176
Published Date: 11 October 2016
The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy’s efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients
Zhang B, Zhao L, Yuan Z, Pang Q, Wang P
OncoTargets and Therapy 2016, 9:6161-6169
Published Date: 11 October 2016
RETRACTED ARTICLE: miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52
Chen H, Xu H, Meng YG, Zhang Y, Chen JY, Wei XN
OncoTargets and Therapy 2016, 9:6151-6160
Published Date: 11 October 2016
Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma
Luo J, Cao C, Zhu Y, Liu P, Liu L, Lu K, Zhang N, Zhou N
OncoTargets and Therapy 2016, 9:6147-6150
Published Date: 11 October 2016
Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer
Wu JY, Shih JY
OncoTargets and Therapy 2016, 9:6137-6145
Published Date: 11 October 2016
Prognostic value of microRNA-126 and CRK expression in gastric cancer
Yue S, Shi H, Han J, Zhang T, Zhu W, Zhang D
OncoTargets and Therapy 2016, 9:6127-6135
Published Date: 11 October 2016
Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer
Boér K
OncoTargets and Therapy 2016, 9:6119-6125
Published Date: 11 October 2016
Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas
Auezova R, Ryskeldiev N, Doskaliyev A, Kuanyshev Y, Zhetpisbaev B, Aldiyarova N, Ivanova N, Akshulakov S, Auezova L
OncoTargets and Therapy 2016, 9:6111-6117
Published Date: 11 October 2016
Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
He J, Jin Y, Chen Y, Yao HB, Xia YJ, Ma YY, Wang W, Shao QS
OncoTargets and Therapy 2016, 9:6099-6109
Published Date: 7 October 2016
Primary breast diffuse large B-cell lymphoma in the era of rituximab
Zhang N, Cao C, Zhu Y, Liu P, Liu L, Lu K, Luo J, Zhou N
OncoTargets and Therapy 2016, 9:6093-6097
Published Date: 7 October 2016
IL-10-1082A/G, -592C/A, and -819T/C polymorphisms in association with lung cancer susceptibility: a meta-analysis
Liu L, Zheng F
OncoTargets and Therapy 2016, 9:6083-6091
Published Date: 7 October 2016
Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors
Fan Y, Ma K, Wang C, Ning J, Hu Y, Dong D, Dong X, Geng Q, Li E, Wu Y
OncoTargets and Therapy 2016, 9:6075-6082
Published Date: 6 October 2016
New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?
Van Der Steen N, Caparello C, Rolfo C, Pauwels P, Peters GJ, Giovannetti E
OncoTargets and Therapy 2016, 9:6065-6074
Published Date: 6 October 2016
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
Kashima J, Okuma Y, Hishima T
OncoTargets and Therapy 2016, 9:6059-6063
Published Date: 12 October 2016
Relationships between MGMT promoter methylation and gastric cancer: a meta-analysis
Yu D, Cao T, Han YD, Huang FS
OncoTargets and Therapy 2016, 9:6049-6057
Published Date: 5 October 2016
Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date
Weisel K
OncoTargets and Therapy 2016, 9:6037-6048
Published Date: 5 October 2016
Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
Sun SL, Wang FC, Dou HL, Zhang LQ, Li JW
OncoTargets and Therapy 2016, 9:6029-6036
Published Date: 5 October 2016
Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy
Wang X, Luo Y, Li M, Yan H, Sun M, Fan T
OncoTargets and Therapy 2016, 9:6021-6027
Published Date: 3 October 2016
miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway
Shen B, Yu S, Zhang Y, Yuan Y, Li X, Zhong J, Feng J
OncoTargets and Therapy 2016, 9:6009-6019
Published Date: 3 October 2016
Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer
Liu F, Ai F, Tian L, Liu S, Zhao L, Wang X
OncoTargets and Therapy 2016, 9:5999-6008
Published Date: 3 October 2016
CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma
Li L, Li Y, Zhao J, Fan S, Wang L, Li X
OncoTargets and Therapy 2016, 9:5985-5997
Published Date: 29 September 2016
Association analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case–control study
Huang C, Wang YN, Fan H, Ma X, Tang R, Huan XK, Zhu Y, Xu ZK, Xu H, Yang L
OncoTargets and Therapy 2016, 9:5975-5983
Published Date: 29 September 2016
Expression of OVOL2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma
Fu H, Qi L, Chen L, He Y, Zhang N, Guo H
OncoTargets and Therapy 2016, 9:5963-5973
Published Date: 29 September 2016
Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma
Wei GB, Lu YY, Liao RW, Chen QS, Zhang KQ
OncoTargets and Therapy 2016, 9:5955-5961
Published Date: 28 September 2016
BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects
Abedin SM, Boddy CS, Munshi HG
OncoTargets and Therapy 2016, 9:5943-5953
Published Date: 28 September 2016
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches
Markowitz J, Abrams Z, Jacob NK, Zhang X, Hassani JN, Latchana N, Wei L, Regan KE, Brooks TR, Uppati SR, Levine KM, Bekaii-Saab T, Kendra KL, Lesinski GB, Howard JH, Olencki T, Payne PR, Carson WE III
OncoTargets and Therapy 2016, 9:5931-5941
Published Date: 29 September 2016
The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study
Jia YX, Li TF, Zhang DD, Fan ZM, Fan HJ, Yan J, Chen LJ, Tang H, Qin YR, Li XY
OncoTargets and Therapy 2016, 9:5919-5929
Published Date: 27 September 2016
Combination of cold atmospheric plasma and iron nanoparticles in breast cancer: gene expression and apoptosis study
Jalili A, Irani S, Mirfakhraie R
OncoTargets and Therapy 2016, 9:5911-5917
Published Date: 28 September 2016
Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma
Dong XJ, Li X, Yu J, Yu MA, Yu XL, Liang P
OncoTargets and Therapy 2016, 9:5903-5909
Published Date: 26 September 2016
Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study
Wang Y, Sun XR, Feng WM, Bao Y, Zheng YY
OncoTargets and Therapy 2016, 9:5897-5902
Published Date: 26 September 2016
Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification
Ren T, Lin SD, Wang ZF, Shang AJ
OncoTargets and Therapy 2016, 9:5883-5895
Published Date: 27 September 2016
Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy
Wang L, Bi XW, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ
OncoTargets and Therapy 2016, 9:5875-5881
Published Date: 26 September 2016
The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials
Huang J, Zhang Y, Sheng J, Zhang H, Fang W, Zhan J, Zhou T, Chen Y, Liu L, Zhang L
OncoTargets and Therapy 2016, 9:5867-5874
Published Date: 23 September 2016
Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date
Vachhani P, Chen H
OncoTargets and Therapy 2016, 9:5855-5866
Published Date: 23 September 2016
Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals
Sarcinelli MA, Albernaz MS, Szwed M, Iscaife A, Leite KRM, Junqueira MS, Bernardes ES, da Silva EO, Tavares MIB, Santos-Oliveira R
OncoTargets and Therapy 2016, 9:5847-5854
Published Date: 23 September 2016
Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma
Barrios CH, Herchenhorn D, Chacón M, Cabrera-Galeana P, Sajben P, Zhang K
OncoTargets and Therapy 2016, 9:5839-5845
Published Date: 23 September 2016
Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection
Yu SS, Quinn DI, Dorff TB
OncoTargets and Therapy 2016, 9:5825-5837
Published Date: 23 September 2016
An evaluation of the diagnostic efficacy of fine needle aspiration biopsy in patients operated for a thyroid nodular goiter
Janczak D, Pawlowski W, Dorobisz T, Janczak D, Dorobisz K, Leśniak M, Ziomek A, Chabowski M
OncoTargets and Therapy 2016, 9:5819-5823
Published Date: 22 September 2016
Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors
Yıldız Y, Sokmensuer C, Yalcin S
OncoTargets and Therapy 2016, 9:5809-5817
Published Date: 22 September 2016
Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
Xing J, Luo Y, Wang X, Gao M, Sun M, Ding X, Fan T, Yu J
OncoTargets and Therapy 2016, 9:5803-5808
Published Date: 22 September 2016
A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature
Zhang C, Zhang W, Mu D, Shi X, Zhao L
OncoTargets and Therapy 2016, 9:5797-5802
Published Date: 22 September 2016
Apparent diffusion coefficient values detected by diffusion-weighted imaging in the prognosis of patients with locally advanced esophageal squamous cell carcinoma receiving chemoradiation
Liu S, Zhen F, Sun N, Chen J, Cao Y, Zhang S, Cheng H, Ge X, Sun X
OncoTargets and Therapy 2016, 9:5791-5796
Published Date: 21 September 2016
A case report and literature review of primary resistant Hodgkin lymphoma: a response to anti-PD-1 after failure of autologous stem cell transplantation and brentuximab vedotin
Xu PP, Wang F, Guan CY, Ouyang J, Shao XY, Chen B
OncoTargets and Therapy 2016, 9:5781-5789
Published Date: 21 September 2016
Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis
Xiao J, Zou Y, Lu X, Xie B, Yu Q, He B, He B, Chen Q
OncoTargets and Therapy 2016, 9:5771-5779
Published Date: 21 September 2016
Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer
Wang X, Teng F, Kong L, Yu J
OncoTargets and Therapy 2016, 9:5761-5770
Published Date: 20 September 2016
The expression of NEDD9 and E-cadherin correlates with metastasis and poor prognosis in triple-negative breast cancer patients
Li P, Sun T, Yuan Q, Pan G, Zhang J, Sun D
OncoTargets and Therapy 2016, 9:5751-5759
Published Date: 19 September 2016
The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer
Jiang HC, Chen CS, Sun QM, Wu J, Qiu LJ, Gao CE, Liu WQ, Yang J, Jun N, Dong J
OncoTargets and Therapy 2016, 9:5737-5750
Published Date: 26 September 2016
Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study
Chen XR, Liang JZ, Ma SX, Fang WF, Zhou NN, Liao H, Li DL, Chen LK
OncoTargets and Therapy 2016, 9:5729-5736
Published Date: 19 September 2016
Proton beam therapy: clinical utility and current status in prostate cancer
Yamoah K, Johnstone PA
OncoTargets and Therapy 2016, 9:5721-5727
Published Date: 16 September 2016
A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer
Zhai N, Xia Y, Yin R, Liu J, Gao F
OncoTargets and Therapy 2016, 9:5713-5720
Published Date: 16 September 2016
Identifying module biomarkers from gastric cancer by differential correlation network
Liu X, Chang X
OncoTargets and Therapy 2016, 9:5701-5711
Published Date: 19 September 2016
Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients [Retraction]
Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L
OncoTargets and Therapy 2016, 9:5699-5700
Published Date: 20 September 2016
Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer
Ai D, Guan Y, Liu XJ, Zhang CF, Wang P, Liang HL, Guo QS
OncoTargets and Therapy 2016, 9:5693-5698
Published Date: 16 September 2016
MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma
Lin K, Xu T, He BS, Pan YQ, Sun HL, Peng HX, Hu XX, Wang SK
OncoTargets and Therapy 2016, 9:5679-5692
Published Date: 15 September 2016
Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
Doan HQ, Silapunt S, Migden MR
OncoTargets and Therapy 2016, 9:5671-5678
Published Date: 14 September 2016
Weekly nanoparticle albumin bound-paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma
Wang HY, Yao ZH, Tang H, Zhao Y, Zhang XS, Yao SN, Yang SJ, Liu YY
OncoTargets and Therapy 2016, 9:5663-5669
Published Date: 23 September 2016
Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma
Tian C, Zhang Y
OncoTargets and Therapy 2016, 9:5659-5661
Published Date: 13 September 2016
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass
Takatori E, Shoji T, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Sugiyama T
OncoTargets and Therapy 2016, 9:5651-5657
Published Date: 13 September 2016
The association of PTEN hypermethylation and breast cancer: a meta-analysis
Luo S, Chen J, Mo X
OncoTargets and Therapy 2016, 9:5643-5650
Published Date: 12 September 2016
Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas
Halani SH, Adamson DC
OncoTargets and Therapy 2016, 9:5629-5642
Published Date: 12 September 2016
Eribulin in the management of inoperable soft-tissue sarcoma: patient selection and survival
Thomas C, Movva S
OncoTargets and Therapy 2016, 9:5619-5627
Published Date: 9 September 2016
Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms
Ko SH, Baeg MK, Bae WJ, Kim P, Choi MG
OncoTargets and Therapy 2016, 9:5611-5617
Published Date: 9 September 2016
Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients
Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulaslı M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C
OncoTargets and Therapy 2016, 9:5603-5609
Published Date: 9 September 2016
Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma
Wang J, Liu F, Ao P, Li X, Zheng H, Wu D, Zhang N, She J, Yuan J, Wu X
OncoTargets and Therapy 2016, 9:5597-5602
Published Date: 9 September 2016
Role of post mastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes
Cihan YB, Sarigoz T
OncoTargets and Therapy 2016, 9:5587-5595
Published Date: 9 September 2016
Proton therapy for early stage prostate cancer: is there a case?
Chan TY, Tan PW, Tang JI
OncoTargets and Therapy 2016, 9:5577-5586
Published Date: 9 September 2016
The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis
Wei BJ, Yao MY, Xing CY, Wang W, Yao J, Hong Y, Liu Y, Fu PF
OncoTargets and Therapy 2016, 9:5567-5575
Published Date: 8 September 2016
Accelerated partial breast irradiation in an Asian population: dosimetric findings and preliminary results of a multicatheter interstitial program
Koh YV, Tan PW, Buhari SA, Iau P, Chan CW, Shen L, Tan SH, Tang JI
OncoTargets and Therapy 2016, 9:5561-5566
Published Date: 8 September 2016
Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
Xian Y, Zhang S, Wang X, Qin J, Wang W, Wu H
OncoTargets and Therapy 2016, 9:5553-5560
Published Date: 7 September 2016
The clinical effects of low-dose splenic irradiation combined with chest three-dimensional conformal radiotherapy on patients with locally advanced non-small-cell lung cancer: a randomized clinical trial
Yu H, Qu Y, Shang Q, Yan C, Jiang P, Wang X, Liang D, Jiang T
OncoTargets and Therapy 2016, 9:5545-5552
Published Date: 7 September 2016
Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity
Assadi A, Najafabadi VS, Shandiz SAS, Boroujeni AS, Ashrafi S, Vaziri AZ, Ghoreishi SM, Aghasadeghi MR, Ebrahimi SES, Pirali-Hamedani M, Ardestani MS
OncoTargets and Therapy 2016, 9:5531-5543
Published Date: 7 September 2016
Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socio-economic changes
Banas T, Juszczyk G, Pitynski K, Nieweglowska D, Ludwin A, Czerw A
OncoTargets and Therapy 2016, 9:5521-5530
Published Date: 7 September 2016
Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population
Hua RX, Zhuo ZJ, Shen GP, Zhu J, Zhang SD, Xue WQ, Li XZ, Zhang PF, He J, Jia WH
OncoTargets and Therapy 2016, 9:5513-5519
Published Date: 7 September 2016
Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report
Garcia-Recio M, Martinez-Serra J, Bento L, Ramos R, Gines J, Daumal J, Sampol A, Gutierrez A
OncoTargets and Therapy 2016, 9:5507-5511
Published Date: 7 September 2016
Sunitinib: the antiangiogenic effects and beyond
Hao Z, Sadek I
OncoTargets and Therapy 2016, 9:5495-5505
Published Date: 8 September 2016
Osimertinib making a breakthrough in lung cancer targeted therapy
Zhang H
OncoTargets and Therapy 2016, 9:5489-5493
Published Date: 6 September 2016
Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers
Jin CY, Zhang XY, Sun M, Zhang YF, Zhang GX, Wang B
OncoTargets and Therapy 2016, 9:5483-5488
Published Date: 6 September 2016
A comparison study of pancreatic acinar cell carcinoma with ductal adenocarcinoma using computed tomography in Chinese patients
Wang Q, Wang X, Guo R, Li G
OncoTargets and Therapy 2016, 9:5475-5481
Published Date: 6 September 2016
Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence
Wang X, Goldstein D, Crowe PJ, Yang JL
OncoTargets and Therapy 2016, 9:5461-5473
Published Date: 6 September 2016
Association between insulin-like growth factor-binding protein-3 polymorphism -202 A/C and the risk of prostate cancer: a meta-analysis
Qin Z, Li X, Tang J, Jiang X, Yu Y, Wang C, Xu W, Hua Y, Yu B, Zhang W
OncoTargets and Therapy 2016, 9:5451-5459
Published Date: 6 September 2016
Identifying candidate agents for lung adenocarcinoma by walking the human interactome
Sun Y, Zhang R, Jiang Z, Xia R, Zhang J, Liu J, Chen F
OncoTargets and Therapy 2016, 9:5439-5450
Published Date: 1 September 2016
Clinical potential of necitumumab in non-small cell lung carcinoma
Genova C, Hirsch FR
OncoTargets and Therapy 2016, 9:5427-5437
Published Date: 31 August 2016
Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial–mesenchymal transition
Cao D, Ding Q, Yu W, Gao M, Wang Y
OncoTargets and Therapy 2016, 9:5417-5425
Published Date: 30 August 2016
Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies: a meta-analysis
Wang H, Ma B, Gao P, Song Y, Xu Q, Hu Y, Zhang C, Wang Z
OncoTargets and Therapy 2016, 9:5405-5416
Published Date: 30 August 2016
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example
Gerratana L, De Maglio G, De Pellegrin A, Follador A, Rihawi K, Pizzolitto S, Puglisi F, Fasola G
OncoTargets and Therapy 2016, 9:5399-5404
Published Date: 30 August 2016
Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer
Lv S, Fang M, Yang J, Zhan W, Jia Y, Xu H, Song T
OncoTargets and Therapy 2016, 9:5389-5397
Published Date: 6 September 2016
Pitavastatin suppressed liver cancer cells in vitro and in vivo
You HY, Zhang WJ, Xie XM, Zheng ZH, Zhu HL, Jiang FZ
OncoTargets and Therapy 2016, 9:5383-5388
Published Date: 29 August 2016
Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer
Feng J, Gou J, Jia J, Yi T, Cui T, Li Z
OncoTargets and Therapy 2016, 9:5371-5381
Published Date: 29 August 2016
Limb-salvage treatment of en-block resected distal femoral tumors with endoprosthesis of all-polyethylene tibial component: a 9-year follow-up study
Tang F, Zhou Y, Min L, Zhang WL, Shi R, Luo Y, Duan H, Tu CQ
OncoTargets and Therapy 2016, 9:5361-5369
Published Date: 13 September 2016
ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway
Jiang J, Liu Y, Tang Y, Li L, Zeng R, Zeng S, Zhong M
OncoTargets and Therapy 2016, 9:5349-5360
Published Date: 29 August 2016
The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis
Song XY, Li BY, Zhou EX, Wu FX
OncoTargets and Therapy 2016, 9:5339-5347
Published Date: 26 August 2016
Knockdown of peroxisome proliferator-activated receptor gamma coactivator-1 alpha increased apoptosis of human endometrial cancer HEC-1A cells
Yang H, Yang R, Liu H, Ren Z, Wang C, Li D, Ma X
OncoTargets and Therapy 2016, 9:5329-5338
Published Date: 24 August 2016
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
Deng Y, Pang Q, Miao RC, Chen W, Zhou YY, Bi JB, Liu SS, Zhang JY, Qu K, Liu C
OncoTargets and Therapy 2016, 9:5317-5328
Published Date: 24 August 2016
Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
Lin DZ, Qu N, Shi RL, Lu ZW, Ji QH, Wu WL
OncoTargets and Therapy 2016, 9:5307-5316
Published Date: 24 August 2016
Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells
Zhu L, Huang FZ, Deng G, Nie W, Huang W, Xu HB, Zheng SP, Yi ZJ, Wan T
OncoTargets and Therapy 2016, 9:5297-5305
Published Date: 24 August 2016
Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1
Nakahara Y, Takagi Y, Hosomi Y, Kagei A, Yamamoto T, Sawada T, Yomota M, Okuma Y, Mikura S, Okamura T
OncoTargets and Therapy 2016, 9:5287-5295
Published Date: 24 August 2016
An isolated orbital mass with proptosis and diplopia: an uncommon metastasis from intracranial olfactory neuroblastoma in a Chinese patient
Shen JQ, Cui HG, Feng S
OncoTargets and Therapy 2016, 9:5281-5286
Published Date: 24 August 2016
Expression and prognostic significance of unique ULBPs in pancreatic cancer
Chen J, Zhu XX, Xu H, Fang HZ, Zhao JQ
OncoTargets and Therapy 2016, 9:5271-5279
Published Date: 25 August 2016
Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma
Guo HS, Xing YH, Mu AL, Li X, Li TS, Bian X, Yang CM, Zhang XL, Liu YF, Wang XG
OncoTargets and Therapy 2016, 9:5257-5270
Published Date: 25 August 2016
MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer
Liu D, Xia H, Wang F, Chen C, Long J
OncoTargets and Therapy 2016, 9:5245-5255
Published Date: 23 August 2016
Prognostic significance of TAZ expression in various cancers: a meta-analysis
Feng J, Ren P, Gou J, Li Z
OncoTargets and Therapy 2016, 9:5235-5244
Published Date: 23 August 2016
Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis
Xu Y, Yan C, Hao Z, Zhou J, Fan S, Tai S, Yang C, Zhang L, Liang C
OncoTargets and Therapy 2016, 9:5225-5233
Published Date: 22 August 2016
Evaluation of the characteristics of hepatic focal nodular hyperplasia: correlation between dynamic contrast-enhanced multislice computed tomography and pathological findings
Zhang HT, Gao XY, Xu QS, Chen YT, Song YP, Yao ZW
OncoTargets and Therapy 2016, 9:5217-5224
Published Date: 22 August 2016
Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: an intention-to-treat analysis
Lei JY, Zhu JQ, Li ZH, Gong RX, Wei T
OncoTargets and Therapy 2016, 9:5209-5216
Published Date: 22 August 2016
B-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancer
Zhao Q, Gui T, Qian Q, Li L, Shen K
OncoTargets and Therapy 2016, 9:5203-5208
Published Date: 22 August 2016
Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT
Zhang Y, Huang SN, Leng YH, Chen X, Liu TT, Wang HL, Wei FL, Luo DZ, Chen G, Wei ZX
OncoTargets and Therapy 2016, 9:5195-5202
Published Date: 29 August 2016
MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway
Xiao J, Lin HY, Zhu YY, Zhu YP, Chen LW
OncoTargets and Therapy 2016, 9:5181-5193
Published Date: 22 August 2016
Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study
Huang WT, Wang HL, Yang H, Ren FH, Luo YH, Huang CQ, Liang YY, Liang HW, Chen G, Dang YW
OncoTargets and Therapy 2016, 9:5163-5180
Published Date: 22 August 2016
EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy
Chang H, Oh J, Zhang X, Kim YJ, Lee JH, Lee CT, Chung JH, Lee JS
OncoTargets and Therapy 2016, 9:5153-5162
Published Date: 19 August 2016
Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma
Qu Z, Yuan CH, Yin CQ, Guan Q, Chen H, Wang FB
OncoTargets and Therapy 2016, 9:5143-5152
Published Date: 18 August 2016
Co-expression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance
Jia W, Wang W, Ji CS, Niu JY, Lv YJ, Zhou HC, Hu B
OncoTargets and Therapy 2016, 9:5133-5142
Published Date: 18 August 2016
Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma
Lv X, Xia WX, Ke LR, Yang J, Qiu WZ, Yu YH, Liang H, Huang XJ, Liu GY, Zeng Q, Guo X, Xiang YQ
OncoTargets and Therapy 2016, 9:5123-5131
Published Date: 18 August 2016
Comparison of long-term survival between temozolomide-based chemoradiotherapy and radiotherapy alone for patients with low-grade gliomas after surgical resection
Gai XJ, Wei YM, Tao HM, An DZ, Sun JT, Li BS
OncoTargets and Therapy 2016, 9:5117-5121
Published Date: 17 August 2016
Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment
El-Osta HE, Shahid K, Mills GM, Peddi P
OncoTargets and Therapy 2016, 9:5101-5116
Published Date: 16 August 2016
MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK
Cheng Y, Zhang X, Li P, Yang C, Tang J, Deng X, Yang X, Tao J, Lu Q, Li P
OncoTargets and Therapy 2016, 9:5091-5099
Published Date: 16 August 2016
The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review
Han Y, Shi K, Zhou SJ, Yu DP, Liu ZD
OncoTargets and Therapy 2016, 9:5081-5090
Published Date: 16 August 2016
Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel
Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C
OncoTargets and Therapy 2016, 9:5073-5080
Published Date: 12 August 2016
Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis
Huang WT, Chen ZX, He RQ, Wu YZ, Yin SY, Liang XN, Chen G, Yang H, Peng ZG, Yang LH
OncoTargets and Therapy 2016, 9:5061-5071
Published Date: 12 August 2016
Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells
Liu P, Zhang H, Wu X, Guo L, Wang F, Xia G, Chen B, Yin H, Wang Y, Li X
OncoTargets and Therapy 2016, 9:5049-5059
Published Date: 12 August 2016
New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer
Zhou JC, Guo JF, Teng RY, Wang QC, Wang J, Wei Q, Li ZD, Shen JG, Wang LB
OncoTargets and Therapy 2016, 9:5041-5047
Published Date: 12 August 2016
PD-L1 expression in human cancers and its association with clinical outcomes
Wang X, Teng FF, Kong L, Yu JM
OncoTargets and Therapy 2016, 9:5023-5039
Published Date: 12 August 2016
Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model
Shi RL, Qu N, Yang SW, Ma B, Lu ZW, Wen D, Sun GH, Wang Y, Ji QH
OncoTargets and Therapy 2016, 9:5015-5022
Published Date: 12 August 2016
Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9
Wang T, Ma SC, Qi X, Tang X, Cui D, Wang Z, Chi J, Li P, Zhai B
OncoTargets and Therapy 2016, 9:5005-5014
Published Date: 12 August 2016
Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer
Wang SW, Ren J, Yan YL, Xue CF, Tan L, Ma XW
OncoTargets and Therapy 2016, 9:4993-5003
Published Date: 16 August 2016
Successful treatment of angiosarcoma of the scalp with apatinib: a case report
Ji G, Hong L, Yang P
OncoTargets and Therapy 2016, 9:4989-4992
Published Date: 11 August 2016
Clinical implications of transforming growth factor-beta–induced gene-h3 protein expression in lung cancer
He CJ, Sun DW, Bai X, Li YB, Xu H, Xu SD
OncoTargets and Therapy 2016, 9:4983-4987
Published Date: 11 August 2016
ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study
Sun SX, Wang ZH, Tang F, Hu PC, Yang ZT, Xue C, Gong J, Shi L, Xie CH
OncoTargets and Therapy 2016, 9:4975-4981
Published Date: 11 August 2016
Anorectal melanoma metastatic to the breast: a case report and review of the literature
Feng L, Qi DJ, Zhang QF
OncoTargets and Therapy 2016, 9:4969-4974
Published Date: 10 August 2016
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases
Zhang Y, Luo J, He RQ, Huang WT, Li ZY, Li P, Dang YW, Chen G, Li SK
OncoTargets and Therapy 2016, 9:4959-4968
Published Date: 10 August 2016
Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned
Pinilla-Ibarz J, Sweet KL, Corrales-Yepez GM, Komrokji RS
OncoTargets and Therapy 2016, 9:4937-4957
Published Date: 10 August 2016
Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting
Seber S, Solmaz D, Yetisyigit T
OncoTargets and Therapy 2016, 9:4929-4935
Published Date: 9 August 2016
A rare case report of primary bone lymphoma and a brief review of the literature
Wang J, Fan S, Liu J, Song B,
OncoTargets and Therapy 2016, 9:4923-4928
Published Date: 9 August 2016
Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
Ma C, Lu B, Diao C, Zhao K, Wang X, Ma B, Lu B, Sun E
OncoTargets and Therapy 2016, 9:4917-4922
Published Date: 8 August 2016
Incidental gallbladder cancer after cholecystectomy: 1990 to 2014
Dorobisz T, Dorobisz K, Chabowski M, Pawłowski W, Janczak D, Patrzałek D, Janczak D
OncoTargets and Therapy 2016, 9:4913-4916
Published Date: 8 August 2016
The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
Zhang XL, Yu JM, Li MH, Zhu H, Sun XD, Kong L
OncoTargets and Therapy 2016, 9:4901-4911
Published Date: 8 August 2016
High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway
Yang XY, Zhang MY, Zhou Q, Wu SY, Zhao Y, Gu WY, Pan J, Cen JN, Chen ZX, Guo WG, Chen CS, Yan WH, Hu SY
OncoTargets and Therapy 2016, 9:4887-4899
Published Date: 8 August 2016
A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
Zhu L, Li X, Shen Y, Cao Y, Fang X, Chen J, Yuan Y
OncoTargets and Therapy 2016, 9:4879-4886
Published Date: 8 August 2016
Modulation of expression of the nuclear receptor NR0B2 (small heterodimer partner 1) and its impact on proliferation of renal carcinoma cells
Prestin K, Olbert M, Hussner J, Isenegger TL, Gliesche DG, Böttcher K, Zimmermann U, Meyer zu Schwabedissen HE
OncoTargets and Therapy 2016, 9:4867-4878
Published Date: 8 August 2016
Oncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer – SGC-7901cell line
Jiang Z, Liu Y, Wang C
OncoTargets and Therapy 2016, 9:4859-4866
Published Date: 9 August 2016
Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future?
Thumallapally N, Yu H, Asti D, Vennepureddy A, Terjanian T
OncoTargets and Therapy 2016, 9:4843-4858
Published Date: 5 August 2016
Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
Xu W, Kuang M, Gong Y, Cao C, Chen J, Tang C
OncoTargets and Therapy 2016, 9:4833-4842
Published Date: 4 August 2016
PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis
Qian D, Cheng J, Ding X, Chen X, Chen X, Guan Y, Zhang B, Wang J, Er P, Qiu M, Zeng X, Guo Y, Wang H, Zhao L, Xie D, Yuan Z, Wang P, Pang Q
OncoTargets and Therapy 2016, 9:4821-4831
Published Date: 3 August 2016
A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer
Karakas Y, Esin E, Lacin S, Ceyhan K, Heper AO, Yalcin S
OncoTargets and Therapy 2016, 9:4815-4820
Published Date: 3 August 2016
Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients
Gu X, Gao XS, Xiong W, Guo W, Han L, Bai Y, Peng C, Cui M, Xie M
OncoTargets and Therapy 2016, 9:4805-4813
Published Date: 2 August 2016
Efficacy of targeted agents in the treatment of elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis
Chen J, Chen J, Wu X, Shi T, Kang M
OncoTargets and Therapy 2016, 9:4797-4803
Published Date: 2 August 2016
Cutaneous basal cell carcinoma arising within a keloid scar: a case report
Goder M, Kornhaber R, Bordoni D, Winkler E, Haik J, Tessone A
OncoTargets and Therapy 2016, 9:4793-4796
Published Date: 2 August 2016
Comparison of planning target volumes based on three-dimensional and four-dimensional CT imaging of thoracic esophageal cancer
Wang W, Li JB, Zhang YJ, Shao Q, Xu M, Fan TY, Wang JZ
OncoTargets and Therapy 2016, 9:4785-4791
Published Date: 2 August 2016
Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma
Chen YJ, Chen CC, Huang HL
OncoTargets and Therapy 2016, 9:4773-4783
Published Date: 1 August 2016
Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cells
Zhang Y, Chang R, Li MQ, Zhao K, Zheng HZ, Zhou XD
OncoTargets and Therapy 2016, 9:4763-4771
Published Date: 1 August 2016
Risk factors and patterns of lymph node involvement in primary gastric large B-cell lymphoma: implications for target definition
Zhang X, Wang P, Zhao L, Yuan Z, Wang P
OncoTargets and Therapy 2016, 9:4757-4762
Published Date: 29 July 2016
Oral administration of sunitinib malate for long-term survival of a patient with multiple lung metastases from renal leiomyosarcoma
Li X, Gao H, Tang C, Liu X
OncoTargets and Therapy 2016, 9:4753-4756
Published Date: 29 July 2016
Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study
Nakamura T, Matsumine A, Yamada S, Tsukushi S, Kawanami K, Ohno T, Katagiri H, Sugiura H, Yamada K, Yamada Y, Sudo A, Nishida Y
OncoTargets and Therapy 2016, 9:4747-4751
Published Date: 29 July 2016
Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis
Wang J, Zhu C
OncoTargets and Therapy 2016, 9:4737-4746
Published Date: 29 July 2016
RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines
Moela P, Motadi LR
OncoTargets and Therapy 2016, 9:4721-4735
Published Date: 29 July 2016
Primary yolk sac tumor of the gluteus: a case report and literature review
Li B, Jiang QQ, Zhang ST, Zhou Y, Zhang QF, OuYang L
OncoTargets and Therapy 2016, 9:4715-4719
Published Date: 2 August 2016
MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4
Yu M, Lin Y, Zhou Y, Jin H, Hou B, Wu Z, Li Z, Jian Z, Sun J
OncoTargets and Therapy 2016, 9:4705-4714
Published Date: 29 July 2016
Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy
Nemecek R, Berkovcova J, Radova L, Kazda T, Mlcochova J, Vychytilova-Faltejskova P, Slaby O, Svoboda M
OncoTargets and Therapy 2016, 9:4695-4703
Published Date: 28 July 2016
The impact of the extent of surgical resection on survival of gastric cancer patients
Angelov KG, Vasileva MB, Grozdev KS, Toshev SY, Sokolov MB, Todorov GT
OncoTargets and Therapy 2016, 9:4687-4694
Published Date: 28 July 2016
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
Azzariti A, Brunetti O, Porcelli L, Graziano G, Iacobazzi RM, Signorile M, Scarpa A, Lorusso V, Silvestris N
OncoTargets and Therapy 2016, 9:4681-4686
Published Date: 28 July 2016
Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
Tang N, Wang Z
OncoTargets and Therapy 2016, 9:4671-4679
Published Date: 27 July 2016
Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer
Sun X, Wang J, Liu J, Chen S, Liu X
OncoTargets and Therapy 2016, 9:4661-4669
Published Date: 27 July 2016
Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer
Liu C, Huang Z, Wang QS, Sun B, Ding LJ, Meng XY, Wu SK
OncoTargets and Therapy 2016, 9:4653-4660
Published Date: 27 July 2016
Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patients
Xia WK, Lin QF, Shen D, Liu ZL, Su J, Mao WD
OncoTargets and Therapy 2016, 9:4645-4652
Published Date: 26 July 2016
Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review
Wang HY, Zhu H, Kong L, Yu JM
OncoTargets and Therapy 2016, 9:4639-4644
Published Date: 26 July 2016
MiR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2
Xu L, Shen B, Chen TT, Dong P
OncoTargets and Therapy 2016, 9:4629-4637
Published Date: 26 July 2016
Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study
Mu Y, Wang WH, Xie JP, Zhang YX, Yang YP, Zhou CH
OncoTargets and Therapy 2016, 9:4617-4627
Published Date: 25 July 2016
Identification of crucial microRNAs and genes in hypoxia-induced human lung adenocarcinoma cells
Geng Y, Deng L, Su D, Xiao J, Ge D, Bao Y, Jing H
OncoTargets and Therapy 2016, 9:4605-4616
Published Date: 25 July 2016
Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL
Xie ZB, Wang XB, Fu DL, Zhong JH, Yang XW, Li LQ
OncoTargets and Therapy 2016, 9:4593-4603
Published Date: 25 July 2016
Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
Sun Y, Hou L, Yang Y, Xie H, Yang Y, Li Z, Zhao H, Gao W, Su B
OncoTargets and Therapy 2016, 9:4583-4591
Published Date: 25 July 2016
Network analysis reveals potential markers for pediatric adrenocortical carcinoma
Kulshrestha A, Suman S, Ranjan R
OncoTargets and Therapy 2016, 9:4569-4581
Published Date: 26 July 2016
Clinical observation of gene expression-guided chemoradiation therapy for nonsurgical esophageal squamous cell carcinoma patients: a retrospective analysis of 36 cases
Yang Z, Dai HH, Lv DX, Feng AL, Shu WB, Han JQ
OncoTargets and Therapy 2016, 9:4561-4568
Published Date: 25 July 2016
Green synthesis, characterization, and anticancer activity of hyaluronan/zinc oxide nanocomposites
Namvar F, Azizi S, Rahman HS, Mohamad R, Rasedee A, Soltani M, Rahim RA
OncoTargets and Therapy 2016, 9:4549-4559
Published Date: 26 July 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-oesophageal junction adenocarcinoma
Davidson M, Smyth EC, Cunningham D
OncoTargets and Therapy 2016, 9:4539-4548
Published Date: 25 July 2016
The effect of clove-based herbal mouthwash on radiation-induced oral mucositis in patients with head and neck cancer: a single-blind randomized preliminary study
Kong M, Hwang DS, Yoon SW, Kim J
OncoTargets and Therapy 2016, 9:4533-4538
Published Date: 22 July 2016
Efficacy of pemetrexed-based regimen in relapsed advanced thymic epithelial tumors and its association with thymidylate synthase level
Qian X, Song Z
OncoTargets and Therapy 2016, 9:4527-4531
Published Date: 22 July 2016
Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies
Ma JT, Sun X, Huang LT, Xiong ZC, Yuan M, Zhang SL, Han CB
OncoTargets and Therapy 2016, 9:4517-4526
Published Date: 22 July 2016
MicroRNA-490 inhibits tumorigenesis and progression in breast cancer
Zhao L, Zheng XY
OncoTargets and Therapy 2016, 9:4505-4516
Published Date: 22 July 2016
Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies
Jiang X, Zhang M, Bai XY, Li S, Wu H
OncoTargets and Therapy 2016, 9:4491-4503
Published Date: 22 July 2016
Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis
Luo T, Chen J, Liu JJ, Li H, You XM, Wang HL, Zhu SL, Li LQ
OncoTargets and Therapy 2016, 9:4483-4489
Published Date: 21 July 2016
Clinical significance of TIPE expression in gastric carcinoma
Hu R, Qiu X, Hong S, Meng L, Hong X, Qiu J, Yang J, Zhuang G, Liu Z
OncoTargets and Therapy 2016, 9:4473-4481
Published Date: 25 July 2016
Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery
Ammendola M, Sacco R, Sammarco G, Piardi T, Zuccalà V, Patruno R, Zullo A, Zizzo N, Nardo B, Marech I, Crovace A, Gadaleta CD, Pessaux P, Ranieri G
OncoTargets and Therapy 2016, 9:4465-4471
Published Date: 21 July 2016
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
Chen YJ, Fang LW, Su WC, Hsu WY, Yang KC, Huang HL
OncoTargets and Therapy 2016, 9:4453-4464
Published Date: 20 July 2016
Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
Pham PV, Le HT, Vu BT, Pham VQ, Le PM, Phan NLC, Trinh NV, Nguyen HTL, Nguyen ST, Nguyen TL, Phan NK
OncoTargets and Therapy 2016, 9:4441-4451
Published Date: 21 July 2016
Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature
Deptala A, Romanowicz A, Czerw A, Walecki J, Rogowski W, Nasierowska-Guttmejer A
OncoTargets and Therapy 2016, 9:4435-4440
Published Date: 20 July 2016
JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway
Liu Y, Wang YR, Ding GH, Yang TS, Yao L, Hua J, He ZG, Qian MP
OncoTargets and Therapy 2016, 9:4425-4433
Published Date: 20 July 2016
Functions and mechanisms of long noncoding RNAs in lung cancer
Peng ZZ, Zhang CF, Duan CJ
OncoTargets and Therapy 2016, 9:4411-4424
Published Date: 20 July 2016
FAT10 is associated with the malignancy and drug resistance of non-small cell lung cancer
Xue F, Zhu L, Meng QW, Wang L, Chen XS, Zhao YB, Xing Y, Wang XY, Cai L
OncoTargets and Therapy 2016, 9:4397-4409
Published Date: 19 July 2016
MK-2206 co-treatment with 5-fluorouracil or doxorubicin enhances chemosensitivity and apoptosis in gastric cancer by attenuation of Akt phosphorylation
Jin PP, Wong CC, Mei SB, He XK, Qian Y, Sun LM
OncoTargets and Therapy 2016, 9:4387-4396
Published Date: 19 July 2016
The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer
Huang WS, Nie WW, Zhang WW, Wang YR, Zhu A, Guan XX
OncoTargets and Therapy 2016, 9:4377-4385
Published Date: 19 July 2016
Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies
Bai K, Cai Q, Jiang Y, Lv L
OncoTargets and Therapy 2016, 9:4369-4375
Published Date: 19 July 2016
Inhibition of microRNA-126 promotes the expression of Spred1 to inhibit angiogenesis in hepatocellular carcinoma after transcatheter arterial chemoembolization: in vivo study
Ji JS, Xu M, Song JJ, Zhao ZW, Chen MJ, Chen WQ, Tu JF, Yang XM
OncoTargets and Therapy 2016, 9:4357-4367
Published Date: 19 July 2016
Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer
Ricciardi GR, Franchina T, Russo A, Schifano S, Ferraro G, Adamo V
OncoTargets and Therapy 2016, 9:4351-4355
Published Date: 21 July 2016
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction
Lu X, Duan L, Xie H, Lu X, Lu D, Lu D, Jiang N, Chen Y
OncoTargets and Therapy 2016, 9:4343-4349
Published Date: 18 July 2016
Association between CD14 SNP -159 C/T and gastric cancer: an independent case–control study and an updated meta-analysis
Gong AM, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, Xu CQ, Wang ZY
OncoTargets and Therapy 2016, 9:4337-4342
Published Date: 18 July 2016
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance
Pyszniak M, Tabarkiewicz J, Łuszczki JJ
OncoTargets and Therapy 2016, 9:4323-4336
Published Date: 18 July 2016
Ectopic micronodular thymoma with lymphoid stroma in the cervical region: a rare case associated with Langerhans cells proliferation
Yu M, Meng Y, Xu B, Zhao L, Zhang QF
OncoTargets and Therapy 2016, 9:4317-4322
Published Date: 18 July 2016
MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12
Liang T, Li L, Cheng Y, Ren C, Zhang G
OncoTargets and Therapy 2016, 9:4307-4315
Published Date: 15 July 2016
Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literature
Zhu YC, Xu CW, Ye XQ, Yin MX, Zhang JX, Du KQ, Zhang ZH, Hu J
OncoTargets and Therapy 2016, 9:4301-4305
Published Date: 15 July 2016
Clinical study on the influence of motion and other factors on stereotactic radiotherapy in the treatment of adrenal gland tumor
Wang J, Li F, Dong Y, Song Y, Yuan Z
OncoTargets and Therapy 2016, 9:4295-4299
Published Date: 15 July 2016
Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma
Tang WW, Liu ZH, Yang TX, Wang HJ, Cao XF
OncoTargets and Therapy 2016, 9:4289-4293
Published Date: 14 July 2016
Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies
Wu JY, Hu LR, Chen MY, Cao WJ, Chen HC, He TP
OncoTargets and Therapy 2016, 9:4277-4288
Published Date: 14 July 2016
Theaflavins suppress tumor growth and metastasis via the blockage of the STAT3 pathway in hepatocellular carcinoma
Shao JP, Meng QY, Li YY
OncoTargets and Therapy 2016, 9:4265-4275
Published Date: 14 July 2016
Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma
Sun P, Chen C, Zhang F, Yang H, Bi XW, An X, Wang FH, Jiang WQ
OncoTargets and Therapy 2016, 9:4257-4264
Published Date: 13 July 2016
Comparison of tumor markers using different detection devices [Retraction]
Tao R, Tu SH, Liu C, Yang Q, Zhu M, Shen JF
OncoTargets and Therapy 2016, 9:4255-4256
Published Date: 15 July 2016
Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis
Liu FT, Xue QZ, Zhu PQ, Luo HL, Zhang Y, Hao TF
OncoTargets and Therapy 2016, 9:4247-4254
Published Date: 12 July 2016
Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
Zhang YF, Wei W, Wang JH, Xu L, Jian PE, Xiao CZ, Zhong XP, Shi M, Guo RP
OncoTargets and Therapy 2016, 9:4239-4246
Published Date: 12 July 2016
Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial–mesenchymal transition, invasion, and metastasis in pancreatic cancer cells
Chen J, Wang S, Su J, Chu G, You H, Chen Z, Sun H, Chen B, Zhou M
OncoTargets and Therapy 2016, 9:4225-4237
Published Date: 11 July 2016
Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
Zhang H, Chen R, Yang S, Liu W, Li K, Zhang H, Zhu X, Chen B
OncoTargets and Therapy 2016, 9:4215-4224
Published Date: 11 July 2016
Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy
Bai H, Xu J, Yang H, Jin B, Lou Y, Wu D, Han B
OncoTargets and Therapy 2016, 9:4207-4213
Published Date: 11 July 2016
Decreased expression of SLC39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer
Xu XM, Wang CG, Zhu YD, Chen WH, Shao SL, Jiang FN, Liao QD
OncoTargets and Therapy 2016, 9:4197-4205
Published Date: 11 July 2016
Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation
Zhu Y, Li M, Kong L, Yu J
OncoTargets and Therapy 2016, 9:4187-4196
Published Date: 11 July 2016
Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations
Chen D, Song Z, Cheng G
OncoTargets and Therapy 2016, 9:4181-4186
Published Date: 8 July 2016
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
von Au A, Milloth E, Diel I, Stefanovic S, Hennigs A, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C
OncoTargets and Therapy 2016, 9:4173-4180
Published Date: 8 July 2016
Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis
Qie YK, Nian XW, Liu XS, Hu HL, Zhang CW, Xie LG, Han RF, Wu CL, Xu Y
OncoTargets and Therapy 2016, 9:4163-4171
Published Date: 7 July 2016
Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer
Teng Y, Wang ZT, Ma L, Zhang L, Guo Y, Gu M, Wang ZY, Wang Y, Yue W
OncoTargets and Therapy 2016, 9:4151-4162
Published Date: 7 July 2016
Blood oxygenation level-dependent magnetic resonance imaging during carbogen breathing: differentiation between prostate cancer and benign prostate hyperplasia and correlation with vessel maturity
Di N, Mao N, Cheng W, Pang H, Ren Y, Wang N, Liu X, Wang B
OncoTargets and Therapy 2016, 9:4143-4150
Published Date: 7 July 2016
Fundamental effects of PD-1 antibody on the body: a brief report
Wang W, Liu B, Liu G, Guo W
OncoTargets and Therapy 2016, 9:4137-4141
Published Date: 7 July 2016
Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy
Chen ZS, Zhu SL, Qi LN, Li LQ
OncoTargets and Therapy 2016, 9:4129-4135
Published Date: 6 July 2016
Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer
Liu H, Huang C, Wu L, Wen B
OncoTargets and Therapy 2016, 9:4121-4127
Published Date: 6 July 2016
Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer
Kotaka M, Ikeda F, Tsujie M, Yoshioka S, Nakamoto Y, Ishii T, Kyogoku T, Kato T, Tsuji A, Kobayashi M
OncoTargets and Therapy 2016, 9:4113-4120
Published Date: 7 July 2016
Expression of G protein-coupled receptor 56 is associated with tumor progression in non-small-cell lung carcinoma patients
Song Y, Li A, Zhang L, Duan L
OncoTargets and Therapy 2016, 9:4105-4112
Published Date: 5 July 2016
Targeted therapy for localized non-small-cell lung cancer: a review
Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaïd C
OncoTargets and Therapy 2016, 9:4099-4104
Published Date: 5 July 2016
The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases
Pieper CC, Meyer C, Sprinkart AM, Block W, Ahmadzadehfar H, Schild HH, Mürtz P, Kukuk GM
OncoTargets and Therapy 2016, 9:4089-4098
Published Date: 5 July 2016
LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo
Chen L, Yang HX, Xiao YB, Tang XX, Li YQ, Han QQ, Fu JP, Yang YY, Zhu YC
OncoTargets and Therapy 2016, 9:4075-4087
Published Date: 4 July 2016
A meta-analysis of combination therapy versus single-agent therapy in anthracycline- and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials
Xu L, Wu X, Hu C, Zhang ZY, Zhang L, Liang SJ, Xu YC, Zhang FC
OncoTargets and Therapy 2016, 9:4061-4074
Published Date: 4 July 2016
Quality of life and cosmetic result of single-port access endoscopic thyroidectomy via axillary approach in patients with papillary thyroid carcinoma
Huang JK, Ma L, Song WH, Lu BY, Huang YB, Dong HM
OncoTargets and Therapy 2016, 9:4053-4059
Published Date: 4 July 2016
Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis
De Santis S, Borghesi C, Ricciardi S, Giovannoni D, Fulvi A, Migliorino MR, Marcassa C
OncoTargets and Therapy 2016, 9:4043-4052
Published Date: 4 July 2016
Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study
He W, Zhang Y, Xiong Y, Dai FJ, Fan QX
OncoTargets and Therapy 2016, 9:4037-4041
Published Date: 1 July 2016
Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma
Xu M, Jia Y, Liu Z, Ding L, Tian R, Gu H, Wang Y, Zhang H, Tu K, Liu Q
OncoTargets and Therapy 2016, 9:4023-4035
Published Date: 1 July 2016
Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
Wei B, Yang S, Zhang B, Feng Y
OncoTargets and Therapy 2016, 9:4015-4022
Published Date: 1 July 2016
Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2–p53 signaling
Xie C, Wu B, Chen B, Shi Q, Guo J, Fan Z, Huang Y
OncoTargets and Therapy 2016, 9:4005-4013
Published Date: 4 July 2016
Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report
Sun B, Ding LJ, Wu S, Meng XY, Song S
OncoTargets and Therapy 2016, 9:3997-4003
Published Date: 1 July 2016
ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman
Gao KH, Li HT, Huang CH, Li HZ, Fang J, Tian C
OncoTargets and Therapy 2016, 9:3993-3996
Published Date: 1 July 2016
Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump
Zeng XL, Wang HH, Meng MB, Wu ZQ, Song YC, Zhuang HQ, Qian D, Li FT, Zhao LJ, Yuan ZY, Wang P
OncoTargets and Therapy 2016, 9:3985-3992
Published Date: 30 June 2016
High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial–mesenchymal transition in gastric cancer
Yan Y, Zhang J, Li JH, Liu X, Wang JZ, Qu HY, Wang JS, Duan XY
OncoTargets and Therapy 2016, 9:3975-3983
Published Date: 30 June 2016
Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
Yang H, Yang R, Liu H,α Ren Z, Kong F, Li D, Ma X
OncoTargets and Therapy 2016, 9:3963-3973
Published Date: 30 June 2016
Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression
Li Y, Xu Q, Liu J, He C, Yuan Q, Xing C, Yuan Y
OncoTargets and Therapy 2016, 9:3951-3962
Published Date: 4 July 2016
RETRACTED ARTICLE: The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells
Xing YN, Zhang JY, Xu HM
OncoTargets and Therapy 2016, 9:3939-3949
Published Date: 29 June 2016
Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma
Yan Y, Xie M, Zhang L, Zhou X, Xie H, Zhou L, Zheng S, Wang W
OncoTargets and Therapy 2016, 9:3925-3937
Published Date: 30 June 2016
Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review
Xia QS, Xu J, Chen HY, Gao YZ, Gong FL, Hu LY, Yang L
OncoTargets and Therapy 2016, 9:3917-3923
Published Date: 29 June 2016
Meta-analysis of cold-knife conization versus loop electrosurgical excision procedure for cervical intraepithelial neoplasia
Jiang YM, Chen CX, Li L
OncoTargets and Therapy 2016, 9:3907-3915
Published Date: 29 June 2016
Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma
Zhang B, Li R, Chang CX, Han Y, Shi SB, Tian J
OncoTargets and Therapy 2016, 9:3901-3906
Published Date: 29 June 2016
Association between pesticide exposure and risk of kidney cancer: a meta-analysis
Xie B, Hu YF, Liang Z, Liu B, Zheng XY, Xie LP
OncoTargets and Therapy 2016, 9:3893-3900
Published Date: 28 June 2016
Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis
Zhang CX, Wang SY, Chen SQ, Yang SL, Wan L, Xiong B
OncoTargets and Therapy 2016, 9:3883-3891
Published Date: 27 June 2016
Internal mammary sentinel lymph node biopsy: abandon or persist?
Qiu PF, Liu YB, Wang YS
OncoTargets and Therapy 2016, 9:3879-3882
Published Date: 27 June 2016
Relationship between serum carcinoembryonic antigen level and epidermal growth factor receptor mutations with the influence on the prognosis of non-small-cell lung cancer patients
Cai ZX
OncoTargets and Therapy 2016, 9:3873-3878
Published Date: 27 June 2016
The clinical significance of γ-catenin in acute myeloid leukemia
Xu J, Wu W, Shen W, Liu P
OncoTargets and Therapy 2016, 9:3861-3871
Published Date: 27 June 2016
Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis
Wang HS, Nie XB, Wu RB, Yuan HW, Ma YH, Liu XL, Zhang JY, Deng XL, Na Q, Jin HY, Bian YC, Gao YM, Wang YD, Chen WD
OncoTargets and Therapy 2016, 9:3849-3860
Published Date: 27 June 2016
The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus
Bai T, Chen J, Xie ZB, Wu FX, Wang SD, Liu JJ, Li LQ
OncoTargets and Therapy 2016, 9:3841-3848
Published Date: 27 June 2016
LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition
Lai F, Liu Q, Liu X, Ji M, Xie P, Chen X
OncoTargets and Therapy 2016, 9:3829-3840
Published Date: 24 June 2016
Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β-catenin signaling pathway
Fu X, Li H, Liu C, Hu B, Li T, Wang Y
OncoTargets and Therapy 2016, 9:3815-3827
Published Date: 24 June 2016
Superiority of helical tomotherapy on liver sparing and dose escalation in hepatocellular carcinoma: a comparison study of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy
Zhao QQ, Wang RB, Zhu J, Jin LZ, Zhu KL, Xu XQ, Feng R, Jiang SM, Qi ZH, Yin Y
OncoTargets and Therapy 2016, 9:3807-3813
Published Date: 24 June 2016
Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
Song G, Ni H, Zou L, Wang S, Tian F, Liu H, Cho WC
OncoTargets and Therapy 2016, 9:3799-3805
Published Date: 23 June 2016
Prognostic significance of metastatic lymph node ratio in squamous cell carcinoma of the cervix
Li C, Liu WH, Cheng YF
OncoTargets and Therapy 2016, 9:3791-3797
Published Date: 23 June 2016
Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort
Wu ZB, Si ZM, Qian S, Liu LX, Qu XD, Zhou B, Zhang W, Wang GZ, Liu R, Wang JH
OncoTargets and Therapy 2016, 9:3783-3789
Published Date: 23 June 2016
Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trials
Liu XQ, Liu XD, Qiao TK, Chen W, Yuan SJ
OncoTargets and Therapy 2016, 9:3771-3781
Published Date: 30 June 2016
In vitro-activated tumor-specific T lymphocytes prolong the survival of patients with advanced gastric cancer: a retrospective cohort study
Kuai J, Yang F, Li GJ, Fang XJ, Gao BQ
OncoTargets and Therapy 2016, 9:3763-3770
Published Date: 23 June 2016
Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment
Qi RX, Qiao TK, Zhuang XB
OncoTargets and Therapy 2016, 9:3753-3762
Published Date: 23 June 2016
The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib
Medina TM, Lewis KD
OncoTargets and Therapy 2016, 9:3739-3752
Published Date: 22 June 2016
Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies
Zhang M, Fang T, Wang K, Mei H, Lv Z, Wang F, Cai Z, Liang C
OncoTargets and Therapy 2016, 9:3727-3737
Published Date: 22 June 2016
Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
Wang J, Wang B, Chu H, Yao Y
OncoTargets and Therapy 2016, 9:3711-3726
Published Date: 22 June 2016
Correlation of primary middle and distal esophageal cancers motion with surrounding tissues using four-dimensional computed tomography
Wang W, Li J, Zhang Y, Shao Q, Xu M, Guo B, Shang D
OncoTargets and Therapy 2016, 9:3705-3710
Published Date: 22 June 2016
Risk of venous and arterial thromboembolic events associated with anti-VEGF agents in advanced non-small-cell lung cancer: a meta-analysis and systematic review
Zhang D, Zhang X, Zhao C
OncoTargets and Therapy 2016, 9:3695-3704
Published Date: 21 June 2016
Can GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reports
Liu H, Shi W, Zhao L, Dai D, Gao J, Kong X
OncoTargets and Therapy 2016, 9:3683-3694
Published Date: 21 June 2016
Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment
Bonanno L, Zago G, Marulli G, Del Bianco P, Schiavon M, Pasello G, Polo V, Canova F, Tonetto F, Loreggian L, Rea F, Conte PF, Favaretto A
OncoTargets and Therapy 2016, 9:3671-3681
Published Date: 21 June 2016
Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study
Ma X, Wang J, Xu Y, Zhang W, Liu J, Cao X, He A, Wang F, Gu L, Lei B, Wang J
OncoTargets and Therapy 2016, 9:3661-3669
Published Date: 20 June 2016
Potential role of S-adenosylmethionine in osteosarcoma development
Shi H, Mu WD, Zhang B, Meng T, Zhang ST, Zhou DS
OncoTargets and Therapy 2016, 9:3653-3659
Published Date: 20 June 2016
MicroRNA-190 regulates FOXP2 genes in human gastric cancer
Jia WZ, Yu T, An Q, Yang H, Zhang Z, Liu X, Xiao G
OncoTargets and Therapy 2016, 9:3643-3651
Published Date: 20 June 2016
The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma
Shen ED, Liu B, Yu XS, Xiang ZF, Huang HY
OncoTargets and Therapy 2016, 9:3633-3642
Published Date: 20 June 2016
A systematic review and meta-analysis of the risk of diarrhea associated with vandetanib treatment in carcinoma patients
Huo Z, Yu S, Hong S, Cao X, Xiu L, Liao Z, Li Y, Xiao H
OncoTargets and Therapy 2016, 9:3621-3631
Published Date: 20 June 2016
Roles of microRNA-99 family in human glioma
Zhang MY, Guo Y, Wu J, Chen FH, Dai ZJ, Fan SS, Li PC, Song T
OncoTargets and Therapy 2016, 9:3613-3619
Published Date: 20 June 2016
XuefuZhuyu Tang exerts antitumor effects by inhibiting glioma cell metastasis and invasion via regulating tumor microenvironment
Liu JM, Zhang J, Huang LW, Zhu XH, Chen W, Hu P
OncoTargets and Therapy 2016, 9:3603-3612
Published Date: 17 June 2016
High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis
Chen XY, Ru GQ, Ma YY, Xie J, Chen WY, Wang HJ, Wang SB, Li L, Jin KT, He XL, Mou XZ
OncoTargets and Therapy 2016, 9:3595-3602
Published Date: 16 June 2016
Bilateral breast adenocarcinomas with EML4—ALK fusion in a patient with multiple metastases successfully treated with crizotinib: is lung the primary site?
Liu C, Ding L, Sun B, Wu S,
OncoTargets and Therapy 2016, 9:3589-3593
Published Date: 16 June 2016
MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway
Zhang H, Cao H, Xu D, Zhu K
OncoTargets and Therapy 2016, 9:3579-3588
Published Date: 16 June 2016
1p/19q codeletion and RET rearrangements in small-cell lung cancer
Lu H, Xu H, Xie F, Qin J, Han N, Fan Y, Mao W
OncoTargets and Therapy 2016, 9:3571-3577
Published Date: 16 June 2016
Association between GSTP1 Ile105Val polymorphism and urinary system cancer risk: evidence from 51 studies
Zhang Y, Yuan Y, Chen Y, Wang Z, Li F, Zhao Q
OncoTargets and Therapy 2016, 9:3565-3569
Published Date: 15 June 2016
miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1
Zhang C, Chen X, Chen X, Wang X, Ji A, Jiang L, Sang F, Li F
OncoTargets and Therapy 2016, 9:3555-3563
Published Date: 15 June 2016
Intensity-modulated radiotherapy for gliomas: dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue
Yang Z, Zhang Z, Wang X, Hu Y, Lyu Z, Huo L, Wei R, Fu J, Hong J
OncoTargets and Therapy 2016, 9:3545-3554
Published Date: 15 June 2016
MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor
Xiao Y, Tian Q, He J, Huang M, Yang C, Gong L
OncoTargets and Therapy 2016, 9:3535-3544
Published Date: 15 June 2016
Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer
Li K, Chen F, Xie H
OncoTargets and Therapy 2016, 9:3525-3533
Published Date: 14 June 2016
Cigarette smoking and risk of adult glioma: a meta-analysis of 24 observational studies involving more than 2.3 million individuals
Li HX, Peng XX, Zong Q, Zhang K, Wang MX, Liu YZ, Han GL
OncoTargets and Therapy 2016, 9:3511-3523
Published Date: 14 June 2016
Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy
Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X, Li W
OncoTargets and Therapy 2016, 9:3501-3509
Published Date: 13 June 2016
Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysis
Shi J, Duan Y, Pan L, Zhou X
OncoTargets and Therapy 2016, 9:3493-3500
Published Date: 13 June 2016
PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis
Han F, Hu R, Yang H, Liu J, Sui J, Xiang X, Wang F, Chu L, Song S
OncoTargets and Therapy 2016, 9:3485-3492
Published Date: 13 June 2016
Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells
Liu Y, Sun B, Liu T, Zhao X, Wang X, Li Y, Meng J, Gu Q, Liu F, Dong X, Liu P, Sun R, Zhao N
OncoTargets and Therapy 2016, 9:3473-3484
Published Date: 13 June 2016
The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
Song WH, Ma HS
OncoTargets and Therapy 2016, 9:3465-3471
Published Date: 15 June 2016
Transcription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cells
Ma H, Yao Y, Wang C, Zhang L, Cheng L, Wang Y, Wang T, Liang E, Jia H, Ye Q, Hou M, Feng F
OncoTargets and Therapy 2016, 9:3451-3463
Published Date: 13 June 2016
Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
Zhang MM, Wei W, Liu JL, Yang HW, Jiang Y, Tang W, Li QY, Liao XM
OncoTargets and Therapy 2016, 9:3443-3450
Published Date: 8 June 2016
Administration of polysaccharide from Panax notoginseng prolonged the survival of H22 tumor-bearing mice
Li HY, Gu LL, Zhong YY, Chen YJ, Zhang L, Zhang AR, Sobol RW, Chen T, Li J
OncoTargets and Therapy 2016, 9:3433-3441
Published Date: 8 June 2016
Comparative efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: a systematic review and meta-analysis
Wang H, Man L, Li G, Huang G, Wang J
OncoTargets and Therapy 2016, 9:3423-3432
Published Date: 8 June 2016
GPR30 decreases with vascular aging and promotes vascular smooth muscle cells maintaining differentiated phenotype and suppressing migration via activation of ERK1/2
Huang F, Yin J, Li K, Li Y, Qi H, Fang L, Yuan C, Liu W, Wang M, Li X
OncoTargets and Therapy 2016, 9:3415-3422
Published Date: 7 June 2016
The prognostic roles of ALDH1 isoenzymes in gastric cancer
Li K, Guo X, Wang Z, Li X, Bu Y, Bai X, Zheng L, Huang Y
OncoTargets and Therapy 2016, 9:3405-3414
Published Date: 7 June 2016
CEBPA mutations in patients with de novo acute myeloid leukemia: data analysis in a Chinese population
Su L, Gao SJ, Liu XL, Tan YH, Wang L, Li W
OncoTargets and Therapy 2016, 9:3399-3403
Published Date: 3 June 2016
A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors
Jiang Z, Zhang J, Li Z, Liu Y, Wang D, Han G
OncoTargets and Therapy 2016, 9:3387-3398
Published Date: 3 June 2016
Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma
Yuan CS, Yang K, Tang H, Chen D
OncoTargets and Therapy 2016, 9:3381-3386
Published Date: 3 June 2016
Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors
Pop LA, Pileczki V, Cojocneanu-Petric RM, Petrut B, Braicu C, Jurj AM, Buiga R, Achimas-Cadariu P, Berindan-Neagoe I
OncoTargets and Therapy 2016, 9:3369-3380
Published Date: 2 June 2016
Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression
Zhang W, Zhou H, Yu Y, Li J, Li H, Jiang D, Chen Z, Yang D, Xu Z, Yu Z
OncoTargets and Therapy 2016, 9:3359-3368
Published Date: 2 June 2016
ACC interleukin-10 gene promoter haplotype as a breast cancer risk factor predictor among Jordanian females
Atoum MF
OncoTargets and Therapy 2016, 9:3353-3357
Published Date: 2 June 2016
Fast-track surgery protocol in elderly patients undergoing laparoscopic radical gastrectomy for gastric cancer: a randomized controlled trial
Liu G, Jian F, Wang X, Chen L
OncoTargets and Therapy 2016, 9:3345-3351
Published Date: 2 June 2016
Significant association between long non-coding RNA HOTAIR polymorphisms and cancer susceptibility: a meta-analysis
Zhang J, Liu X, You LH, Zhou RZ
OncoTargets and Therapy 2016, 9:3335-3343
Published Date: 1 June 2016
Synthetic treatment of intracranial peripheral primitive neuroectodermal tumor with multiple metastasis: a case report
Zhang Y, Li HS, Li ZJ, Liu M, Yang L, Fan LY, Huang CS, Li BS
OncoTargets and Therapy 2016, 9:3327-3333
Published Date: 2 June 2016
Filtered selection coupled with support vector machines generate a functionally relevant prediction model for colorectal cancer
Gabere MN, Hussein MA, Aziz MA
OncoTargets and Therapy 2016, 9:3313-3325
Published Date: 1 June 2016
The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer
Choi YJ, Chang WJ, Shin SW, Park KH, Kim ST, Kim YH
OncoTargets and Therapy 2016, 9:3307-3312
Published Date: 1 June 2016
Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer
Qiao XJ, Zhai XR, Wang JH, Zhao XT, Yang XJ, Lv JL, Ma L, Zhang LN, Wang Y, Zhang SC, Yue WT
OncoTargets and Therapy 2016, 9:3299-3305
Published Date: 1 June 2016
Clinical significance of B7-H6 protein expression in astrocytoma
Guo JG, Guo CC, He ZQ, Liu ZG, Wang Y, Mou YG
OncoTargets and Therapy 2016, 9:3291-3297
Published Date: 31 May 2016
MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET
Jin H, Yu M, Lin Y, Hou B, Wu Z, Li Z, Sun J
OncoTargets and Therapy 2016, 9:3281-3289
Published Date: 31 May 2016
Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma
Nema R, Vishwakarma S, Agarwal R, Panday RK, Kumar A
OncoTargets and Therapy 2016, 9:3269-3280
Published Date: 31 May 2016
Anti-colorectal cancer effect of interleukin-2 and interferon-β fusion gene driven by carcinoembryonic antigen promoter
Wang Y, Wang M, Li Y
OncoTargets and Therapy 2016, 9:3259-3267
Published Date: 30 May 2016
Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma
Zhang Y, Zhu SL, Chen J, Li LQ
OncoTargets and Therapy 2016, 9:3249-3257
Published Date: 30 May 2016
The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis
Chen ZL, Shen YW, Li ST, Li CL, Zhang LX, Yang J, Lv M, Lin YY, Wang X, Yang J
OncoTargets and Therapy 2016, 9:3233-3247
Published Date: 30 May 2016
Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells
Liang Y, Mafuvadze B, Aebi JD, Hyder SM
OncoTargets and Therapy 2016, 9:3223-3232
Published Date: 30 May 2016
The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy
Feng X, Zhu K, Liu J, Chen J, Tang J, Liang Y, Jin R, Liang X, Cai X
OncoTargets and Therapy 2016, 9:3213-3221
Published Date: 30 May 2016
Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis
Chen XW, Zhao JH, Li AL, Gao P, Sun JX, Song YX, Liu JJ, Chen P, Wang ZN
OncoTargets and Therapy 2016, 9:3205-3212
Published Date: 27 May 2016
Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review
Zhao F, Li MH, Kong L, Zhang GL, Yu JM
OncoTargets and Therapy 2016, 9:3197-3204
Published Date: 27 May 2016
Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer
Ang YLE, Lim JS, Soo RA
OncoTargets and Therapy 2016, 9:3187-3195
Published Date: 30 May 2016
Clinical features and treatment of squamous cell carcinoma of the breast
Zhang XM, Zhang BZ, Zang FL, Zhao LJ, Yuan ZY, Wang P
OncoTargets and Therapy 2016, 9:3181-3185
Published Date: 27 May 2016
Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy
Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, Li X, Tang F, Wang Z, Sun H, Wang L, Zhou S, Wang X, Jia Y, Hu T, Gui J, Wan D, Ma D, Li S, Wang S
OncoTargets and Therapy 2016, 9:3171-3179
Published Date: 27 May 2016
Do signal transduction cascades influence survival in triple-negative breast cancer? A preliminary study
Mumm JN, Kölbl AC, Jeschke U, Andergassen U
OncoTargets and Therapy 2016, 9:3163-3169
Published Date: 26 May 2016
Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency
Bian X, Wu P, Sha H, Qian H, Wang Q, Cheng L, Yang Y, Yang M, Liu B
OncoTargets and Therapy 2016, 9:3153-3162
Published Date: 27 May 2016
A preliminary study of pamidronic acid downregulation of angiogenic factors IGF-1/PECAM-1 expression in circulating level in bone metastatic breast cancer patients
Wang Z, Lei L, Cai X, Chen LY, Yuan M, Yang G, Huang P, Wang X
OncoTargets and Therapy 2016, 9:3147-3152
Published Date: 26 May 2016
Effect of YAP1 silencing on esophageal cancer
Zhao J, Li X, Yang Y, Zhu D, Zhang C, Liu D, Wu K, Zhao S
OncoTargets and Therapy 2016, 9:3137-3146
Published Date: 26 May 2016
Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study [Corrigendum]
Gao S, Zhu G, Lin Y, Fan X, Qian P, Zhu J, Yu Y
OncoTargets and Therapy 2016, 9:3135-3136
Published Date: 27 May 2016
Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis
Dong YW, Shi YQ, He LW, Su PZ
OncoTargets and Therapy 2016, 9:3127-3134
Published Date: 25 May 2016
Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis
Liang JX, Liang Y, Gao W
OncoTargets and Therapy 2016, 9:3113-3125
Published Date: 24 May 2016
MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1
Li Y, Zeng C, Tu M, Jiang W, Dai Z, Hu Y, Deng Z, Xiao W
OncoTargets and Therapy 2016, 9:3101-3111
Published Date: 24 May 2016
Analysis of prostate bed motion using an endorectal balloon and cone beam computed tomography during postprostatectomy radiotherapy
Joo JH, Kim YJ, Kim YS, Cho YP, Lee HY, Jeong CY, Kwak J, Cho BC
OncoTargets and Therapy 2016, 9:3095-3100
Published Date: 24 May 2016
Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301
Han K, Meng W, Zhang JJ, Zhou Y, Wang YL, Su Y, Lin SC, Gan ZH, Sun YN, Min DL
OncoTargets and Therapy 2016, 9:3085-3094
Published Date: 26 May 2016
Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer
Lu Y, Zhou XH, Xu L, Rong CH, Shen C, Bian W
OncoTargets and Therapy 2016, 9:3077-3084
Published Date: 24 May 2016
Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells
Chen GS, Zhou N, Li JQ, Li T, Zhang ZQ, Si ZZ
OncoTargets and Therapy 2016, 9:3067-3076
Published Date: 27 May 2016
URG4 expression is a novel prognostic factor for the progression of nasopharyngeal carcinoma and overall survival of patient
Yu G, Meng QX, Zhang T, Zeng C, He BF, Zhang SS
OncoTargets and Therapy 2016, 9:3059-3065
Published Date: 23 May 2016
Details of out-field regional recurrence after involved-field irradiation with concurrent chemotherapy for locally advanced esophageal squamous cell carcinoma
Zhang X, Yu J, Li M, Zhu H
OncoTargets and Therapy 2016, 9:3049-3057
Published Date: 23 May 2016
Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis
Liu XD, Luo ZY, Peng HX, Jiang H, Xu L
OncoTargets and Therapy 2016, 9:3039-3047
Published Date: 23 May 2016
Expression of VEGF and HIF-1α in locally advanced cervical cancer: potential biomarkers for predicting preoperative radiochemotherapy sensitivity and prognosis
Zhu PF, Ou YJ, Dong YS, Xu PZ, Yuan L
OncoTargets and Therapy 2016, 9:3031-3037
Published Date: 23 May 2016
Image-guided intensity-modulated radiotherapy for refractory bilateral breast cancer in a patient with extensive cutaneous metastasis in the chest and abdominal walls
Lu YF, Lin YC, Chen KH, Shueng PW, Yeh HP, Hsieh CH
OncoTargets and Therapy 2016, 9:3025-3030
Published Date: 23 May 2016
Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports
Sun HL, Pan YQ, He BS, Nie ZL, Lin K, Peng HX, Cho WC, Wang SK
OncoTargets and Therapy 2016, 9:3017-3023
Published Date: 20 May 2016
Targeting gastrointestinal stromal tumors: the role of regorafenib
Schroeder B, Li Z, Cranmer LD, Jones RL, Pollack SM
OncoTargets and Therapy 2016, 9:3009-3016
Published Date: 20 May 2016
Onivyde for the therapy of multiple solid tumors
Zhang H
OncoTargets and Therapy 2016, 9:3001-3007
Published Date: 20 May 2016
Prognostic value of the standardized uptake value maximum change calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging in patients with advanced non-small-cell lung cancer
Jin F, Zhu H, Fu Z, Kong L, Yu J
OncoTargets and Therapy 2016, 9:2993-2999
Published Date: 19 May 2016
Association between cooking oil fume exposure and lung cancer among Chinese nonsmoking women: a meta-analysis
Xue Y, Jiang Y, Jin S, Li Y
OncoTargets and Therapy 2016, 9:2987-2992
Published Date: 19 May 2016
Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer
Cai H, Xu J, Han Y, Lu Z, Han T, Ding Y, Ma L
OncoTargets and Therapy 2016, 9:2975-2986
Published Date: 19 May 2016
Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses
Wang HY, Hsu MK, Wang KH, Tseng CP, Chen FC, Hsu JTA
OncoTargets and Therapy 2016, 9:2961-2973
Published Date: 19 May 2016
Low-grade nasopharyngeal papillary adenocarcinoma: a case report and review of the literature
Wang XL, Yan HJ, Luo YJ, Fan TY
OncoTargets and Therapy 2016, 9:2955-2959
Published Date: 18 May 2016
Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential
Barrientos JC
OncoTargets and Therapy 2016, 9:2945-2953
Published Date: 18 May 2016
Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors
Wu X, Zhang H, Salmani JMM, Fu R, Chen B
OncoTargets and Therapy 2016, 9:2935-2943
Published Date: 17 May 2016
The association of the CYP1A1 Ile462Val polymorphism with head and neck cancer risk: evidence based on a cumulative meta-analysis
Wang Y, Yang H, Duan G, Wang H
OncoTargets and Therapy 2016, 9:2927-2934
Published Date: 17 May 2016
PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population
Wu YB, Lu D, He ZF, Jin CG
OncoTargets and Therapy 2016, 9:2919-2925
Published Date: 17 May 2016
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma
Xu J, Liu X, Yang S, Zhang X, Shi Y
OncoTargets and Therapy 2016, 9:2911-2917
Published Date: 17 May 2016
Comparative effects of different enteral feeding methods in head and neck cancer patients receiving radiotherapy or chemoradiotherapy: a network meta-analysis
Zhang ZH, Zhu Y, Ling Y, Zhang LJ, Wan HW
OncoTargets and Therapy 2016, 9:2897-2909
Published Date: 18 May 2016
Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway
Zhang JY, Jiang H, Xie L, Hu J, Li L, Yang M, Cheng L, Liu BR, Qian XP
OncoTargets and Therapy 2016, 9:2885-2895
Published Date: 24 May 2016
Recent advancements in erythrocytes, platelets, and albumin as delivery systems
Xu PP, Wang RJ, Wang XH, Ouyang J
OncoTargets and Therapy 2016, 9:2873-2884
Published Date: 17 May 2016
miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma
Liu C, Li M, Hu Y, Shi N, Yu H, Liu H, Lian H
OncoTargets and Therapy 2016, 9:2865-2871
Published Date: 19 May 2016
Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma
Karakiewicz PI, Nott L, Joshi A, Kannourakis G, Tarazi J, Alam M
OncoTargets and Therapy 2016, 9:2855-2863
Published Date: 12 May 2016
Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway
Sun Y, Tao C, Huang X, He H, Shi H, Zhang Q, Wu H
OncoTargets and Therapy 2016, 9:2845-2853
Published Date: 12 May 2016
Transcatheter arterial embolization combined with radiofrequency ablation activates CD8+ T-cell infiltration surrounding residual tumors in the rabbit VX2 liver tumors
Duan XH, Li TF, Zhou GF, Han XW, Zheng CS, Chen PF, Feng GS
OncoTargets and Therapy 2016, 9:2835-2844
Published Date: 17 May 2016
Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration
Xu YW, Zheng SB, Chen BS, Wen Y, Zhu SW
OncoTargets and Therapy 2016, 9:2825-2833
Published Date: 12 May 2016
Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?
Shakespeare TP, Wilcox SW, Aherne NJ
OncoTargets and Therapy 2016, 9:2819-2824
Published Date: 11 May 2016
Sophoridinol derivative 05D induces tumor cells apoptosis by topoisomerase1-mediated DNA breakage
Zhao W, Zhang C, Bi C, Ye C, Song D, Liu X, Shao R
OncoTargets and Therapy 2016, 9:2805-2817
Published Date: 11 May 2016
Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cells
Fan SL, Li X, Li LM, Wang LG, Du ZZ, Yang Y, Zhao JS, Li Y
OncoTargets and Therapy 2016, 9:2795-2803
Published Date: 10 May 2016
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor
Redic KA, Hough SM, Price EM
OncoTargets and Therapy 2016, 9:2783-2793
Published Date: 10 May 2016
Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors
Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B
OncoTargets and Therapy 2016, 9:2769-2781
Published Date: 10 May 2016
Prognostic significance of lymphocyte-to-monocyte ratio and CRP in patients with nonmetastatic clear cell renal cell carcinoma: a retrospective multicenter analysis
Xia WK, Wu X, Yu TH, Wu Y, Yao XJ, Hu H
OncoTargets and Therapy 2016, 9:2759-2767
Published Date: 9 May 2016
Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study
Zhou Q, Jiang Y, Yin W, Wang Y, Lu J
OncoTargets and Therapy 2016, 9:2749-2757
Published Date: 9 May 2016
Orbital metastasis as the initial presentation of lung adenocarcinoma: a case report
Sun LC, Qi YL, Sun XD, Yu JM, Meng X
OncoTargets and Therapy 2016, 9:2743-2748
Published Date: 9 May 2016
miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer
Molinari C, Salvi S, Foca F, Teodorani N, Saragoni L, Puccetti M, Passardi A, Tamberi S, Avanzolini A, Lucci E, Calistri D
OncoTargets and Therapy 2016, 9:2735-2742
Published Date: 6 May 2016
Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma
Banzi M, De Blasio S, Lallas A, Longo C, Moscarella E, Alfano R, Argenziano G
OncoTargets and Therapy 2016, 9:2725-2733
Published Date: 6 May 2016
Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile
Zhang M, Li H, Zou D, Gao J
OncoTargets and Therapy 2016, 9:2717-2723
Published Date: 5 May 2016
HER2 induces cell proliferation and invasion of non-small-cell lung cancer by upregulating COX-2 expression via MEK/ERK signaling pathway
Chi F, Wu R, Jin X, Jiang M, Zhu X
OncoTargets and Therapy 2016, 9:2709-2716
Published Date: 5 May 2016
A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy
Wang J, Tian Y, Tang Y, Wang X, Li N, Ren H, Fang H, Feng Y, Wang S, Song Y, Liu Y, Wang W, Li Y, Jin J
OncoTargets and Therapy 2016, 9:2701-2707
Published Date: 5 May 2016
HOXB7 as a promising molecular marker for metastasis in cancers: a meta-analysis
Liu FT, Ou YX, Zhang GP, Qiu C, Luo HL, Zhu PQ
OncoTargets and Therapy 2016, 9:2693-2699
Published Date: 6 May 2016
High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma
Zhao S, Guo W, Li J, Yu W, Guo T, Deng W, Gu C
OncoTargets and Therapy 2016, 9:2683-2692
Published Date: 5 May 2016
Shorter telomere length of T-cells in peripheral blood of patients with lung cancer
Qian Y, Ding T, Wei L, Cao S, Yang L
OncoTargets and Therapy 2016, 9:2675-2682
Published Date: 4 May 2016
Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Luo ZL, Feng C, Hu P, Chen Y, He XF, Li YH, Zhao JB
OncoTargets and Therapy 2016, 9:2667-2674
Published Date: 4 May 2016
Emerging treatment options for myelofibrosis: focus on pacritinib
Chow V, Weissman A, O’Connell CL, Mehrvar A, Akhtari M
OncoTargets and Therapy 2016, 9:2655-2665
Published Date: 4 May 2016
Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis
Liu YX, Wang XS, Wang YF, Hu XC, Yan JQ, Zhang YL, Wang W, Yang RJ, Feng YY, Gao SG, Feng XS
OncoTargets and Therapy 2016, 9:2649-2654
Published Date: 4 May 2016
miR-125b inhibited epithelialal–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7
Hong LQ, Pan F, Jiang HF, Zhang LH, Liu YH, Cai CS, Hua CZ, Luo X, Sun JH, Chen ZJ
OncoTargets and Therapy 2016, 9:2639-2648
Published Date: 4 May 2016
Oncolytic viruses as immunotherapy: progress and remaining challenges
Aurelian L
OncoTargets and Therapy 2016, 9:2627-2637
Published Date: 4 May 2016
Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy [Retraction]
Wei B, Huang Q, Zhong X
OncoTargets and Therapy 2016, 9:2625-2626
Published Date: 5 May 2016
Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer – a meta-analysis
Chen Z, Liu H, Jin W, Ding Z, Zheng S, Yu Y
OncoTargets and Therapy 2016, 9:2615-2624
Published Date: 4 May 2016
Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study
Lin KY, Cheng SM, Tsai SL, Tsai JY, Lin CH, Cheung CHA
OncoTargets and Therapy 2016, 9:2601-2613
Published Date: 3 May 2016
Screening of biomarkers for prediction of response to and prognosis after chemotherapy for breast cancers
Bing F, Zhao Y
OncoTargets and Therapy 2016, 9:2593-2600
Published Date: 2 May 2016
Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients
Tang Q, Hu QY, Piao YF, Hua YH
OncoTargets and Therapy 2016, 9:2585-2591
Published Date: 2 May 2016
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches
Pathan AAK, Panthi B, Khan Z, Koppula PR, Alanazi MS, Sachchidanand, Parine NR, Chourasia M
OncoTargets and Therapy 2016, 9:2575-2584
Published Date: 2 May 2016
Stathmin1 increases radioresistance by enhancing autophagy in non-small-cell lung cancer cells
Zhang X, Ji JF, Yang Y, Zhang J, Shen LF
OncoTargets and Therapy 2016, 9:2565-2574
Published Date: 29 April 2016
Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience
Mu YS, Qin MQ, Wang B, Li SD, Zhu GH, Zhou X, Yang J, Wang K, Lin W, Zheng HY
OncoTargets and Therapy 2016, 9:2557-2563
Published Date: 2 May 2016
Prognostic significance of miR-126 in various cancers: a meta-analysis
Dong Y, Fu C, Guan H, Zhang Z, Zhou T, Li BS
OncoTargets and Therapy 2016, 9:2547-2555
Published Date: 28 April 2016
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen
Salacz ME, Kast RE, Saki N, Brüning A, Karpel-Massler G, Halatsch ME
OncoTargets and Therapy 2016, 9:2535-2545
Published Date: 27 April 2016
Midazolam regulated caspase pathway, endoplasmic reticulum stress, autophagy, and cell cycle to induce apoptosis in MA-10 mouse Leydig tumor cells
So EC, Chen YC, Wang SC, Wu CC, Huang MC, Lai MS, Pan BS, Kang FC, Huang BM
OncoTargets and Therapy 2016, 9:2519-2533
Published Date: 27 April 2016
Paeoniflorin prevents hypoxia-induced epithelial–mesenchymal transition in human breast cancer cells
Zhou Z, Wang S, Song C, Hu Z
OncoTargets and Therapy 2016, 9:2511-2518
Published Date: 27 April 2016
Diagnostic value of BRAFV600E-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis
Su X, Jiang X, Xu X, Wang W, Teng X, Shao A, Teng L
OncoTargets and Therapy 2016, 9:2495-2509
Published Date: 27 April 2016
Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma
Liu X, Ren G, Li L, Xia T
OncoTargets and Therapy 2016, 9:2489-2494
Published Date: 26 April 2016
Tandem mass spectrometry-based newborn screening strategy could be used to facilitate rapid and sensitive lung cancer diagnosis
Huang T, Cao YF, Zeng J, Dong J, Sun XY, Chen JX, Gao P
OncoTargets and Therapy 2016, 9:2479-2487
Published Date: 26 April 2016
Long noncoding RNA expression profile analysis of colorectal cancer and metastatic lymph node based on microarray data
Yang P, Xu ZP, Chen T, He ZY
OncoTargets and Therapy 2016, 9:2465-2478
Published Date: 26 April 2016
Serum biomarker panels for diagnosis of gastric cancer
Tong WH, Ye F, He L, Cui LF, Cui M, Hu Y, Li W, Jiang J, Zhang DY, Suo J
OncoTargets and Therapy 2016, 9:2455-2463
Published Date: 26 April 2016
E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations
Ren X, Wang J, Lin X, Wang X
OncoTargets and Therapy 2016, 9:2447-2453
Published Date: 26 April 2016
Irreversible electroporation: state of the art
Wagstaff PGK, Buijs M, van den Bos W, de Bruin DM, Zondervan PJ, de la Rosette JJMCH, Laguna Pes MP
OncoTargets and Therapy 2016, 9:2437-2446
Published Date: 22 April 2016
Metadherin regulates epithelial–mesenchymal transition in carcinoma
Wang Z, Tang ZY, Yin Z, Wei YB, Liu LF, Yan B, Zhou KQ, Nian YQ, Gao YL, Yang JR
OncoTargets and Therapy 2016, 9:2429-2436
Published Date: 21 April 2016
Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials
Lai XX, Xu RA, Li YP, Yang H
OncoTargets and Therapy 2016, 9:2421-2428
Published Date: 21 April 2016
Complete transthoracic resection of giant posterior mediastinal goiter: case report and review of surgical strategies
Zhao H, Ren D, Liu Y, Li X, Wu Y, Chen G, Chen J
OncoTargets and Therapy 2016, 9:2415-2419
Published Date: 22 April 2016
Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
He YY, Sun WW, Wang Y, Ren SX, Li XF, Li JY, Rivard CJ, Zhou CC, Hirsch FR
OncoTargets and Therapy 2016, 9:2409-2414
Published Date: 21 April 2016
Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis
Zhang C, Huang JY, He ZQ, Weng H
OncoTargets and Therapy 2016, 9:2403-2408
Published Date: 20 April 2016
RNA interference-mediated silencing of speckle-type POZ protein promotes apoptosis of renal cell cancer cells
Liu X, Sun G, Sun X
OncoTargets and Therapy 2016, 9:2393-2402
Published Date: 20 April 2016
AEG-1 as a predictor of sensitivity to neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Wang Y, Jin X, Song H, Meng F
OncoTargets and Therapy 2016, 9:2385-2392
Published Date: 20 April 2016
ROI for outlining an entire tumor is a reliable approach for quantification of lung cancer tumor vascular parameters using CT perfusion
Ma E, Ren A, Gao B, Yang M, Zhao Q, Wang W, Li K
OncoTargets and Therapy 2016, 9:2377-2384
Published Date: 27 April 2016
Vitamin D postpones the progression of epithelial ovarian cancer induced by 7, 12-dimethylbenz [a] anthracene both in vitro and in vivo
Liu LZ, Hu ZY, Zhang HM, Hou YF, Zhang ZL, Zhou GM, Li BY
OncoTargets and Therapy 2016, 9:2365-2375
Published Date: 19 April 2016
Oral vinorelbine: a feasible and safe partner for radiotherapy in the treatment of locally advanced non-small cell lung cancer
Perri F, Lazzari G, Della Vittoria Scarpati G, Silvano G
OncoTargets and Therapy 2016, 9:2359-2364
Published Date: 19 April 2016
Massive chest wall resection and reconstruction for malignant disease
Foroulis CN, Kleontas AD, Tagarakis G, Nana C, Alexiou I, Grosomanidis V, Tossios P, Papadaki E, Kioumis I, Baka S, Zarogoulidis P, Anastasiadis K
OncoTargets and Therapy 2016, 9:2349-2358
Published Date: 19 April 2016
The predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas
Zhang HB, Lu C, Lu YJ, Yu B, Lv FZ, Zhu ZH
OncoTargets and Therapy 2016, 9:2337-2348
Published Date: 20 April 2016
Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer
He Q, Xu Q, Wu W, Chen L, Sun W, Ying JE
OncoTargets and Therapy 2016, 9:2329-2335
Published Date: 20 April 2016
Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer
Zheng WQ, Jiang CH, Li RF
OncoTargets and Therapy 2016, 9:2317-2327
Published Date: 18 April 2016
RETRACTED ARTICLE: MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial–mesenchymal transition
Jiang SB, He XJ, Xia YJ, Hu WJ, Luo JG, Zhang J, Tao HQ
OncoTargets and Therapy 2016, 9:2305-2315
Published Date: 18 April 2016
Carvacrol suppresses proliferation and invasion in human oral squamous cell carcinoma
Dai W, Sun C, Huang S, Zhou Q
OncoTargets and Therapy 2016, 9:2297-2304
Published Date: 18 April 2016
Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People’s Republic of China
Zhou P, Jiang YZ, Hu X, Sun W, Liu YR, Liu F, Luo RC, Shao ZM
OncoTargets and Therapy 2016, 9:2287-2295
Published Date: 18 April 2016
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes
Sochacki AL, Fischer MA, Savona MR
OncoTargets and Therapy 2016, 9:2273-2286
Published Date: 15 April 2016
Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas
Liu C, Li Z, Wu D, Li C, Zhang Y
OncoTargets and Therapy 2016, 9:2265-2271
Published Date: 15 April 2016
DUSP4/MKP2 overexpression is associated with BRAFV600E mutation and aggressive behavior of papillary thyroid cancer
Ma B, Shi RL, Yang SW, Zhou L, Qu N, Liao T, Wang Y, Wang YL, Ji QH
OncoTargets and Therapy 2016, 9:2255-2263
Published Date: 15 April 2016
Esophageal cancer stem cells and implications for future therapeutics
Qian X, Tan C, Wang F, Yang B, Ge Y, Guan Z, Cai J
OncoTargets and Therapy 2016, 9:2247-2254
Published Date: 19 April 2016
RETRACTED ARTICLE: The important tumor suppressor role of PER1 in regulating the cyclin–CDK–CKI network in SCC15 human oral squamous cell carcinoma cells
Fu XJ, Li HX, Yang K, Chen D, Tang H
OncoTargets and Therapy 2016, 9:2237-2245
Published Date: 15 April 2016
Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma
Wu H, Shi XL, Zhang HJ, Song QJ, Yang XB, Hu WD, Mei GL, Chen X, Mao QS, Chen Z
OncoTargets and Therapy 2016, 9:2227-2236
Published Date: 18 April 2016
BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients
Zhao RH, Zhu CH, Li XK, Cao W, Zong H, Cao XG, Hu HY
OncoTargets and Therapy 2016, 9:2221-2226
Published Date: 15 April 2016
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin ZY, Wu YD, Liang YX, Han ZD, Liu JC, Zhong WD
OncoTargets and Therapy 2016, 9:2211-2220
Published Date: 15 April 2016
Short- and long-term outcomes of laparoscopic surgery vs open surgery for transverse colon cancer: a retrospective multicenter study
Kim JW, Kim JY, Kang BM, Lee BH, Kim BC, Park JH
OncoTargets and Therapy 2016, 9:2203-2209
Published Date: 15 April 2016
Ectopic adrenocorticotropic hormone syndrome caused by neuroendocrine tumors of the thymus: 30-year experience with 16 patients at a single institute in the People’s Republic of China
Chen YY, Li SQ, Liu HS, Qin YZ, Li L, Huang C, Bi YL, Meng YX, He J, Zhou XY, Ma DJ
OncoTargets and Therapy 2016, 9:2193-2201
Published Date: 26 April 2016
Association between two interleukin-2 gene polymorphisms and cancer susceptibility: a meta-analysis
Zhang M, Tan X, Huang J, Xie L, Wang H, Shi J, Lu W, Lv Z, Mei H, Liang C
OncoTargets and Therapy 2016, 9:2181-2192
Published Date: 19 April 2016
Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis
Shan N, Zhou W, Zhang S, Zhang Y
OncoTargets and Therapy 2016, 9:2169-2179
Published Date: 13 April 2016
Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails
Zhu G, Zhang X, Wang Y, Xiong H, Zhao Y, Sun F
OncoTargets and Therapy 2016, 9:2153-2168
Published Date: 13 April 2016
Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondrosarcoma cell via activating Notch-1 signaling pathway
Xu FQ, Zhang ZQ, Fang YC, Li XL, Sun Y, Xiong CZ, Yan LQ, Wang Q
OncoTargets and Therapy 2016, 9:2143-2151
Published Date: 13 April 2016
Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma
Zeng FC, Zeng MQ, Huang L, Li YL, Gao BM, Chen JJ, Xue RZ, Tang ZY
OncoTargets and Therapy 2016, 9:2131-2141
Published Date: 12 April 2016
ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen
Sensorn I, Sukasem C, Sirachainan E, Chamnanphon M, Pasomsub E, Trachu N, Supavilai P, Pinthong D, Wongwaisayawan S
OncoTargets and Therapy 2016, 9:2121-2129
Published Date: 12 April 2016
Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis
Zhu SL, Zhong JH, Gong WF, Li H, Li LQ
OncoTargets and Therapy 2016, 9:2111-2119
Published Date: 15 April 2016
Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma
Pang Q, Bi JB, Wang ZX, Xu XS, Qu K, Miao RC, Chen W, Zhou YY, Liu C
OncoTargets and Therapy 2016, 9:2099-2109
Published Date: 12 April 2016
Are compression corsets beneficial for the treatment of breast cancer-related lymphedema? New opportunities in physiotherapy treatment – a preliminary report
Hansdorfer-Korzon R, Teodorczyk J, Gruszecka A, Lass P
OncoTargets and Therapy 2016, 9:2089-2098
Published Date: 7 April 2016
Overexpression of long noncoding RNA HOTTIP promotes tumor invasion and predicts poor prognosis in gastric cancer
Ye H, Liu K, Qian K
OncoTargets and Therapy 2016, 9:2081-2088
Published Date: 7 April 2016
Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes
Sun Y, Joks M, Xu LM, Chen XL, Qian D, You JQ, Yuan ZY
OncoTargets and Therapy 2016, 9:2069-2080
Published Date: 6 April 2016
Use of micro-positron emission tomography with 18F-fallypride to measure the levels of dopamine receptor-D2 and 18F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats
Li P, Gui S, Cao L, Gao H, Bai J, Li C, Zhang Y
OncoTargets and Therapy 2016, 9:2057-2068
Published Date: 6 April 2016
Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects
Yu XJ, Li YL, Yu YD, Lei JH, Wan GX, Cao FJ
OncoTargets and Therapy 2016, 9:2049-2056
Published Date: 6 April 2016
Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial–mesenchymal transition
Wang N, Wang Q, Shen D, Sun X, Cao X, Wu D
OncoTargets and Therapy 2016, 9:2035-2047
Published Date: 6 April 2016
Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma
Chen R, Allibone S, Bartlett NL, Brice P, Chen A, Pose K, Rich L, Bonthapally V, Garfin PM, Fanale M
OncoTargets and Therapy 2016, 9:2027-2034
Published Date: 6 April 2016
The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy
Qie Y, Hu H, Tian D, Zhang Y, Xie L, Xu Y, Wu C
OncoTargets and Therapy 2016, 9:2019-2025
Published Date: 5 April 2016
Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: comments on a meta-analysis by Liang et al
Tu C, He J, Li Z
OncoTargets and Therapy 2016, 9:2017-2018
Published Date: 5 April 2016
Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy
Kwon Y
OncoTargets and Therapy 2016, 9:2007-2016
Published Date: 5 April 2016
Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients
Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L
OncoTargets and Therapy 2016, 9:1997-2005
Published Date: 5 April 2016
Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer
Wen MM, Wang XJ, Sun Y, Xia JH, Fan LB, Xing H, Zhang ZP, Li XF
OncoTargets and Therapy 2016, 9:1989-1995
Published Date: 5 April 2016
Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer
Ma YM, Zhao S
OncoTargets and Therapy 2016, 9:1981-1988
Published Date: 4 April 2016
Triterpenoid saponin flaccidoside II from Anemone flaccida triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors via the MAPK-HO-1 pathway
Han LT, Fang Y, Cao Y, Wu FH, Liu E, Mo GY, Huang F
OncoTargets and Therapy 2016, 9:1969-1979
Published Date: 5 April 2016
Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis
Zhao XT, Liu FZ, Zhang Y, Li PH
OncoTargets and Therapy 2016, 9:1961-1968
Published Date: 4 April 2016
Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancer
Cooper MR, Binkowski C, Hartung J, Towle J
OncoTargets and Therapy 2016, 9:1953-1960
Published Date: 4 April 2016
A genetic variant in large tumor suppressor kinase 2 of Hippo signaling pathway contributes to prognosis of hepatocellular carcinoma
Shen LL, Wen J, Zhao TT, Hu ZB, Song C, Gu DY, He ML, Lee NP, Xu Z, Chen JF
OncoTargets and Therapy 2016, 9:1945-1951
Published Date: 4 April 2016
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
Sacco AG, Worden FP
OncoTargets and Therapy 2016, 9:1927-1943
Published Date: 4 April 2016
Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study
Aktas G, Kus T, Kalender ME, Sevinc A, Camci C, Kul S
OncoTargets and Therapy 2016, 9:1921-1926
Published Date: 1 April 2016
Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
Seow HF, Yip WK, Fifis T
OncoTargets and Therapy 2016, 9:1899-1920
Published Date: 31 March 2016
Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis
Qiao GL, Qi WX, Jiang WH, Chen Y, Ma LJ
OncoTargets and Therapy 2016, 9:1889-1897
Published Date: 31 March 2016
Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis
Meng XY, Liao Y, Liu XP, Li S, Shi MJ, Zeng XT
OncoTargets and Therapy 2016, 9:1875-1888
Published Date: 31 March 2016
Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma
Tao HM, Wei YM, Huang W, Gai XJ, Li BS
OncoTargets and Therapy 2016, 9:1865-1873
Published Date: 31 March 2016
A comparison of dosimetric variance for external-beam partial breast irradiation using three-dimensional and four-dimensional computed tomography
Guo B, Li JB, Wang W, Xu M, Li YK, Liu TH
OncoTargets and Therapy 2016, 9:1857-1863
Published Date: 31 March 2016
Pragmatic medicine in solid cancer: a translational alternative to precision medicine
Brábek J, Rosel D, Fernandes M
OncoTargets and Therapy 2016, 9:1839-1855
Published Date: 5 April 2016
Influence of negative lymph node in No 7 on survival of patients with middle thoracic esophageal squamous cell carcinoma
Zhang JL, Heng XY, Luo Y, Fu QX, Li ZR, Che FY, Li BS
OncoTargets and Therapy 2016, 9:1831-1837
Published Date: 30 March 2016
Tumoral angiogenesis in both adrenal adenomas and nonadenomas: a promising computed tomography biomarker for diagnosis
Wang X, Li K, Sun H, Zhao J, Zhang Z, Zheng L, Li W, Bai R, Zhang G
OncoTargets and Therapy 2016, 9:1823-1830
Published Date: 30 March 2016
Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2
Liu J, Wang H, Wang Y, Li Z, Pan Y, Liu Q, Yang M, Wang J
OncoTargets and Therapy 2016, 9:1813-1822
Published Date: 29 March 2016
Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway
Zhang HJ, Tao J, Sheng L, Hu X, Rong RM, Xu M, Zhu TY
OncoTargets and Therapy 2016, 9:1801-1812
Published Date: 29 March 2016
Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma
Zhao H, Wang T, Wang Y, Yu Y, Wang X, Zhao Z, Yang H, Yan B, Wu X, Da W, Zhang Y
OncoTargets and Therapy 2016, 9:1795-1799
Published Date: 24 March 2016
Identification of colorectal cancer-restricted microRNAs and their target genes based on high-throughput sequencing data
Chang J, Huang L, Cao Q, Liu F
OncoTargets and Therapy 2016, 9:1787-1794
Published Date: 24 March 2016
miR-98 functions as a tumor suppressor in salivary adenoid cystic carcinomas
Liu XN, Zhang WC, Guo H, Yue JL, Zhuo SS
OncoTargets and Therapy 2016, 9:1777-1786
Published Date: 23 March 2016
Tremelimumab: research and clinical development
Comin-Anduix B, Escuin-Ordinas H, Ibarrondo FJ
OncoTargets and Therapy 2016, 9:1767-1776
Published Date: 23 March 2016
A meta-analysis of clinical trials assessing the effect of radiofrequency ablation for breast cancer
Chen J, Zhang C, Li F, Xu L, Zhu H, Wang S, Liu X, Zha X, Ding Q, Ling L, Zhou W, Sun X
OncoTargets and Therapy 2016, 9:1759-1766
Published Date: 23 March 2016
Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation
Morichika D, Kubo T, Gotoda H, Tamura T, Ohashi K, Hotta K, Tabata M, Kurozumi K, Tanimoto M, Kiura K
OncoTargets and Therapy 2016, 9:1753-1758
Published Date: 22 March 2016
Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome
Zhao ZG, Wang DQ, Hu DF, Li YS, Liu SH
OncoTargets and Therapy 2016, 9:1743-1752
Published Date: 23 March 2016
Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes
Wang T, Liu Y, Zhou B, Wang Z, Liang NC, Zhang YD, Dong ZH, Li J
OncoTargets and Therapy 2016, 9:1735-1741
Published Date: 22 March 2016
Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis
Li JJ, Liang L, Liu YR, Luo YH, Liang XN, Luo DZ, Feng ZB, Dang YW, Yang LH, Chen G
OncoTargets and Therapy 2016, 9:1721-1734
Published Date: 21 March 2016
The interleukin-18 gene promoter -607 A/C polymorphism contributes to non-small-cell lung cancer risk in a Chinese population
Jia YC, Zang AM, Jiao SC, Chen SM, Yan F
OncoTargets and Therapy 2016, 9:1715-1719
Published Date: 21 March 2016
Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study
Sun JY, Wu SG, Li FY, Lin HX, He ZY
OncoTargets and Therapy 2016, 9:1707-1713
Published Date: 21 March 2016
Up-regulated expression of phospholipase C, β1 is associated with tumor cell proliferation and poor prognosis in hepatocellular carcinoma
Li J, Zhao X, Wang D, He W, Zhang S, Cao W, Huang Y, Wang L, Zhou S, Luo K
OncoTargets and Therapy 2016, 9:1697-1706
Published Date: 21 March 2016
Statin use and mortality of patients with prostate cancer: a meta-analysis
Meng Y, Liao YB, Xu P, Wei WR, Wang J
OncoTargets and Therapy 2016, 9:1689-1696
Published Date: 21 March 2016
Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis
Shen H, Zhan M, Wang W, Yang D, Wang J
OncoTargets and Therapy 2016, 9:1679-1688
Published Date: 22 March 2016
High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma
Zhao Y, Liu ZG, Tang J, Zou RF, Chen XY, Jiang GM, Qiu YF, Wang H
OncoTargets and Therapy 2016, 9:1671-1677
Published Date: 21 March 2016
Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study
Gao S, Zhu G, Lin Y, Fan X, Qian P, Zhu J, Yu Y
OncoTargets and Therapy 2016, 9:1657-1670
Published Date: 21 March 2016
Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma
Wu MH, Ye XX, Deng XB, Wu YX, Li XF, Zhang L
OncoTargets and Therapy 2016, 9:1647-1656
Published Date: 18 March 2016
Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review
Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito KI, Tateishi A, Yoshizawa A, Takayama F
OncoTargets and Therapy 2016, 9:1641-1646
Published Date: 18 March 2016
Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?
Shakespeare TP, Wilcox SW, Aherne NJ
OncoTargets and Therapy 2016, 9:1635-1639
Published Date: 17 March 2016
miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1
Huang YW, Liu JT, Fan LL, Wang F, Yu HQ, Wei W, Sun GP
OncoTargets and Therapy 2016, 9:1623-1633
Published Date: 17 March 2016
AA-PMe, a novel asiatic acid derivative, induces apoptosis and suppresses proliferation, migration, and invasion of gastric cancer cells
Jing Y, Wang G, Ge Y, Xu M, Tang S, Gong Z
OncoTargets and Therapy 2016, 9:1605-1621
Published Date: 17 March 2016
The CT and US features of Ewing’s sarcoma/primary neuroectodermal tumor of the kidney: two case reports and review of literature
Zhang DF, Li ZH, Gao DP, Yang GJ, Ding YY, Wang GS, Dong XX
OncoTargets and Therapy 2016, 9:1599-1603
Published Date: 17 March 2016
Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma
Zhao J, Chen F, Zhou Q, Pan W, Wang X, Xu J, Ni L, Yang H
OncoTargets and Therapy 2016, 9:1589-1597
Published Date: 17 March 2016
Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Yang CJ, Tsai MJ, Hung JY, Liu TC, Chou SH, Lee JY, Hsu JS, Tsai YM, Huang MS, Chong IW
OncoTargets and Therapy 2016, 9:1579-1587
Published Date: 16 March 2016
The efficacy and safety of nivolumab in the treatment of advanced melanoma: a meta-analysis of clinical trials
Jin CH, Zhang XL, Zhao KL, Xu J, Zhao M, Xu XH
OncoTargets and Therapy 2016, 9:1571-1578
Published Date: 16 March 2016
Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis
Ma M, Yu N
OncoTargets and Therapy 2016, 9:1559-1569
Published Date: 16 March 2016
Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data
Chen C, Zhang LG, Liu J, Han H, Chen N, Yao AL, Kang SS, Gao WX, Shen H, Zhang LJ, Li YP, Cao FH, Li ZG
OncoTargets and Therapy 2016, 9:1545-1557
Published Date: 16 March 2016
Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis
Wu XJ, Zhi Y, He P, Zhou XZ, Zheng J, Chen ZW, Zhou ZS
OncoTargets and Therapy 2016, 9:1535-1543
Published Date: 15 March 2016
miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22
Xiao J, Li Y, Zhang W, Jiang Y, Du B, Tan Y
OncoTargets and Therapy 2016, 9:1525-1534
Published Date: 16 March 2016
Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma
Fu H, Ma C, Guan W, Cheng W, Feng F, Wang H
OncoTargets and Therapy 2016, 9:1519-1523
Published Date: 15 March 2016
Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor
Yang CJ, Tsai MJ, Hung JY, Tsai YM, Lee JY, Chou SH, Liu TC, Shen MC, Huang MS, Chong IW
OncoTargets and Therapy 2016, 9:1511-1518
Published Date: 15 March 2016
Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case–control studies
Zhong JH, Zhao Z, Liu J, Yu HL, Zhou JY, Shi R
OncoTargets and Therapy 2016, 9:1499-1510
Published Date: 15 March 2016
miR-32 inhibits proliferation, epithelial–mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cells
Li L, Wu DP
OncoTargets and Therapy 2016, 9:1489-1498
Published Date: 14 March 2016
Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: a meta-analysis
Ren HY, Zhang YH, Li HY, Xie T, Sun LL, Zhu T, Wang SD, Ye ZM
OncoTargets and Therapy 2016, 9:1477-1487
Published Date: 14 March 2016
Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis
Xiao HQ, Tian RH, Zhang ZH, Du KQ, Ni YM
OncoTargets and Therapy 2016, 9:1471-1476
Published Date: 14 March 2016
Effects of CYP3A5 genetic polymorphism and smoking on the prognosis of non-small-cell lung cancer
Jiang LP, Zhu ZT, He CY
OncoTargets and Therapy 2016, 9:1461-1469
Published Date: 14 March 2016
Predictive value of mutant p53 expression index obtained from nonenhanced computed tomography measurements for assessing invasiveness of ground-glass opacity nodules
Wang W, Li J, Liu R, Zhang A, Yuan Z
OncoTargets and Therapy 2016, 9:1449-1459
Published Date: 14 March 2016
Increased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression
Liu T, Zhang X, Yang Y, Du L, Wang C
OncoTargets and Therapy 2016, 9:1437-1448
Published Date: 11 March 2016
Antitumor activity of pluripotent cell-engineered vaccines and their potential to treat lung cancer in relation to different levels of irradiation
Zhang Y, Duan X, Zhang W, Wu A, Yang H, Wu D, Wei Y, Chen X
OncoTargets and Therapy 2016, 9:1425-1436
Published Date: 11 March 2016
The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines
Cheng W, Feng F, Ma C, Wang H
OncoTargets and Therapy 2016, 9:1415-1423
Published Date: 11 March 2016
Ovarian small-cell carcinoma hypercalcemic type successfully treated: a case report and literature review
Wang JJ, Liu Q, Wu N, Zhou XD, Wang H, Wang X, Tu P, Zhou XJ, Shi QL
OncoTargets and Therapy 2016, 9:1409-1414
Published Date: 11 March 2016
Comparison of preoperative neutrophil–lymphocyte, lymphocyte–monocyte, and platelet–lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy
Song X, Zhang GM, Ma XC, Luo L, Li B, Chai DY, Sun LJ
OncoTargets and Therapy 2016, 9:1399-1407
Published Date: 11 March 2016
A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection
Wang Q, Sun T, Cao Y, Gao P, Dong J, Fang Y, Fang Z, Sun X, Zhu Z
OncoTargets and Therapy 2016, 9:1389-1398
Published Date: 11 March 2016
Quantitative assessment of caveolin-1 G14713A polymorphism and cancer susceptibility in the Asian population
Tang JJ, Wang G, Li Q, Song RF
OncoTargets and Therapy 2016, 9:1381-1387
Published Date: 10 March 2016
Prognostic role of microRNA-150 in various carcinomas: a meta-analysis
Wang W, Wang X, Zhang Y, Wang D, Gao H, Wang L, Gao S
OncoTargets and Therapy 2016, 9:1371-1379
Published Date: 11 March 2016
Impact of the care provided by gynecologic oncologists on outcomes of cervical cancer patients treated with radical hysterectomy
Wu MF, Li J, Lu HW, Wang LJ, Zhang BZ, Lin ZQ
OncoTargets and Therapy 2016, 9:1361-1370
Published Date: 10 March 2016
p53 inhibits the expression of p125 and the methylation of POLD1 gene promoter by downregulating the Sp1-induced DNMT1 activities in breast cancer
Zhang L, Yang WP, Zhu X, Wei CY
OncoTargets and Therapy 2016, 9:1351-1360
Published Date: 10 March 2016
Association of thymidylate synthase expression and clinical outcomes of gastric cancer patients treated with fluoropyrimidine-based chemotherapy: a meta-analysis
Gao YH, Cui JX, Xi HQ, Cai AZ, Shen WS, Li JY, Zhang KC, Wei B, Chen L
OncoTargets and Therapy 2016, 9:1339-1350
Published Date: 9 March 2016
Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma
Lu Z, Yao Y, Song Q, Yang J, Zhao X, Yang P, Kang J
OncoTargets and Therapy 2016, 9:1327-1337
Published Date: 9 March 2016
A prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer
Kim YJ, Park JH, Yun IH, Kim YS
OncoTargets and Therapy 2016, 9:1319-1325
Published Date: 9 March 2016
Diagnostic value of two-dimensional shear wave elastography in papillary thyroid microcarcinoma
Duan SB, Yu J, Li X, Han ZY, Zhai HY, Liang P
OncoTargets and Therapy 2016, 9:1311-1317
Published Date: 9 March 2016
Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer
Zhang Y, Liu G, Wu S, Jiang F, Xie J, Wang Y
OncoTargets and Therapy 2016, 9:1303-1310
Published Date: 29 March 2016
Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
Li MJ, He Q, Li M, Luo F, Guan YS
OncoTargets and Therapy 2016, 9:1291-1302
Published Date: 9 March 2016
Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type
Quan Q, Chen Q, Chen P, Jiang L, Li T, Qiu H, Zhang B
OncoTargets and Therapy 2016, 9:1281-1290
Published Date: 14 March 2016
Association of OPN rs11730582 polymorphism with cancer risk: a meta-analysis
He LL, Wang Y
OncoTargets and Therapy 2016, 9:1275-1280
Published Date: 7 March 2016
Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery
Liu Y, Feng Y, Gao Y, Hou R
OncoTargets and Therapy 2016, 9:1269-1273
Published Date: 7 March 2016
Circulating interleukin-10 levels and human papilloma virus and Epstein–Barr virus-associated cancers: evidence from a Mendelian randomization meta-analysis based on 11,170 subjects
Qu K, Pang Q, Lin T, Zhang L, Gu M, Niu W, Liu C, Zhang M
OncoTargets and Therapy 2016, 9:1251-1267
Published Date: 7 March 2016
The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis
Liu YL, Zhang HM, Pan HM, Bao YH, Xue J, Wang TC, Dong XC, Li XL, Bao HG
OncoTargets and Therapy 2016, 9:1241-1249
Published Date: 7 March 2016
MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1
He X, Wei Y, Wang Y, Liu L, Wang W, Li N
OncoTargets and Therapy 2016, 9:1231-1239
Published Date: 7 March 2016
Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma
Wang J, Li M, Wang Y, Liu X
OncoTargets and Therapy 2016, 9:1221-1230
Published Date: 7 March 2016
Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma
Shankar A, Borin TF, Iskander A, Varma NR, Achyut BR, Jain M, Mikkelsen T, Guo AM, Chwang WB, Ewing JR, Bagher-Ebadian H, Arbab AS
OncoTargets and Therapy 2016, 9:1205-1219
Published Date: 9 March 2016
The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer
Ding X, Qiu L, Zhang L, Xi J, Li D, Huang X, Zhao Y, Wang X, Sun Q
OncoTargets and Therapy 2016, 9:1189-1204
Published Date: 8 March 2016
Profile of farletuzumab and its potential in the treatment of solid tumors
Sato S, Itamochi H
OncoTargets and Therapy 2016, 9:1181-1188
Published Date: 7 March 2016
The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population
Sha N, Xu H, Chen T, Tian DW, Xie WQ, Xie LG, Zhang Y, Xing C, Liu XT, Shen ZH, Wu ZL, Hu HL, Wu CL
OncoTargets and Therapy 2016, 9:1175-1179
Published Date: 7 March 2016
Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials
Yimaer W, Abudouyimu A, Tian Y, Magaoweiya S, Bagedati D, Wen H
OncoTargets and Therapy 2016, 9:1167-1173
Published Date: 7 March 2016
Screening miRNAs for early diagnosis of colorectal cancer by small RNA deep sequencing and evaluation in a Chinese patient population
Wang X, Chen L, Jin H, Wang S, Zhang Y, Tang X, Tang G
OncoTargets and Therapy 2016, 9:1159-1166
Published Date: 7 March 2016
Association between L55M polymorphism in Paraoxonase 1 and cancer risk: a meta-analysis based on 21 studies
Chen L, Lu W, Fang L, Xiong H, Wu X, Zhang M, Wu S, Yu D
OncoTargets and Therapy 2016, 9:1151-1158
Published Date: 4 March 2016
Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization
Hu Y, Chen W, Chen S, Huang Z
OncoTargets and Therapy 2016, 9:1145-1149
Published Date: 3 March 2016
Combined action of EGFR tyrosine kinase inhibitors and whole-brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis
Lu YY, Fan Y
OncoTargets and Therapy 2016, 9:1135-1143
Published Date: 9 March 2016
miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells
Zhang M, Dong BB, Lu M, Zheng MJ, Chen H, Ding JZ, Xu AM, Xu YH
OncoTargets and Therapy 2016, 9:1123-1133
Published Date: 3 March 2016
Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme
Kusumawidjaja G, Gan PZ, Ong WS, Teyateeti A, Dankulchai P, Tan DYH, Chua ET, Chua KL, Tham CK, Wong FY, Chua ML
OncoTargets and Therapy 2016, 9:1115-1122
Published Date: 2 March 2016
YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells
Xiao L, Shi XY, Zhang Y, Zhu Y, Zhu L, Tian W, Zhu BK, Wei ZL
OncoTargets and Therapy 2016, 9:1105-1114
Published Date: 16 March 2016
Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase
Qin T, Zhou NN, Zeng YD, Dinglin XX, Zhao YY, Liu H, Chen LK
OncoTargets and Therapy 2016, 9:1095-1103
Published Date: 1 March 2016
Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma
Li GJ, Xu HW, Ji JJ, Yang F, Gao BQ
OncoTargets and Therapy 2016, 9:1085-1093
Published Date: 1 March 2016
Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective
He DX, Ma X
OncoTargets and Therapy 2016, 9:1077-1084
Published Date: 1 March 2016
SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression
Yan QY, Lou GH, Qian Y, Qin B, Xu XP, Wang YN, Liu YN, Dong XJ
OncoTargets and Therapy 2016, 9:1067-1075
Published Date: 1 March 2016
Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial
Martínez E, Martínez M, Rico M, Hernández B, Casas F, Viñolas N, Pérez-Casas A, Dómine M, Mínguez J
OncoTargets and Therapy 2016, 9:1057-1066
Published Date: 1 March 2016
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
Achyut BR, Arbab AS
OncoTargets and Therapy 2016, 9:1047-1055
Published Date: 1 March 2016
Polymorphisms of vitamin D receptor gene TaqI susceptibility of prostate cancer: a meta-analysis
Fei XW, Liu NN, Li HF, Shen YT, Guo JM, Wu ZQ
OncoTargets and Therapy 2016, 9:1033-1045
Published Date: 1 March 2016
Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment
Kashima J, Horio H, Okuma Y, Hosomi Y, Hishima T
OncoTargets and Therapy 2016, 9:1029-1032
Published Date: 29 February 2016
Quality of life of patients with lung cancer
Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A
OncoTargets and Therapy 2016, 9:1023-1028
Published Date: 29 February 2016
Overexpression of Livin promotes migration and invasion of colorectal cancer cells by induction of epithelial–mesenchymal transition via NF-κB activation
Ge Y, Cao XK, Wang DL, Sun W, Sun HL, Han B, Cui JP, Liu BL
OncoTargets and Therapy 2016, 9:1011-1021
Published Date: 29 February 2016
Orchestrating epigenetic roles targeting ocular tumors
Wen X, Lu L, Zhang H, Fan X
OncoTargets and Therapy 2016, 9:1001-1009
Published Date: 29 February 2016
The pro-apoptotic effects of TIPE2 on AA rat fibroblast-like synoviocytes via regulation of the DR5–caspase–NF-κB pathway in vitro
Shi C, Zhang S, Hong S, Pang J, Yesibulati Y, Yin P, Zhuang G
OncoTargets and Therapy 2016, 9:993-1000
Published Date: 29 February 2016
A comparative study of idarubicin 12 mg/m2 and 8 mg/m2 combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients
Zhou L, Liu X, Liu H, Zhu W, Cai X, Song K, Zheng C, Tang B, Sun Z
OncoTargets and Therapy 2016, 9:985-991
Published Date: 29 February 2016
Analyses of prognostic factors in cases of non-small cell lung cancer with multiple brain metastases
Gong X, Zhou D, Liang S, Zhou C
OncoTargets and Therapy 2016, 9:977-983
Published Date: 1 March 2016
Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer
Ma B, Ma Q, Wang H, Zhang G, Zhang H, Wang X
OncoTargets and Therapy 2016, 9:959-976
Published Date: 29 February 2016
Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer
Liu X, Xu P, Qiu H, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X
OncoTargets and Therapy 2016, 9:949-958
Published Date: 26 February 2016
Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy
Seber S, Gonultas A, Ozturk O, Yetisyigit T
OncoTargets and Therapy 2016, 9:945-948
Published Date: 25 February 2016
Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases
Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H
OncoTargets and Therapy 2016, 9:937-943
Published Date: 25 February 2016
Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer
Shen YW, Zhang XM, Li ST, Lv M, Yang J, Wang F, Chen ZL, Wang BY, Li P, Chen L, Yang J
OncoTargets and Therapy 2016, 9:929-935
Published Date: 24 February 2016
Adjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancer
Lei T, Xu XL, Chen W, Xu YP, Mao WM
OncoTargets and Therapy 2016, 9:921-928
Published Date: 24 February 2016
Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer
Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M
OncoTargets and Therapy 2016, 9:911-919
Published Date: 24 February 2016
Association between three exonuclease 1 polymorphisms and cancer risks: a meta-analysis
Chen ZY, Zheng SR, Zhong JH, Zhuang XD, Zhou JY
OncoTargets and Therapy 2016, 9:899-910
Published Date: 23 February 2016
Interleukin-27 rs153109 polymorphism and the risk of non-small-cell lung cancer in a Chinese population
Ge P, Xiao G
OncoTargets and Therapy 2016, 9:895-898
Published Date: 23 February 2016
Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells
Zheng L, Jiang H, Zhang ZW, Wang KN, Wang QF, Li QL, Jiang T
OncoTargets and Therapy 2016, 9:885-894
Published Date: 23 February 2016
Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients
Jiang C, Hu WM, Liao FX, Yang Q, Chen P, Rong YM, Guo GF, Yin CX, Zhang B, He WZ, Xia LP
OncoTargets and Therapy 2016, 9:877-883
Published Date: 23 February 2016
Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis
Qiang G, Liang C, Xiao F, Yu Q, Wen H, Song Z, Tian Y, Shi B, Guo Y, Liu D
OncoTargets and Therapy 2016, 9:869-876
Published Date: 22 February 2016
Type I enteropathy-associated T-cell lymphoma in the colon of a 29-year-old patient and a brief literature review
Zhang JC, Wang Y, Wang XF, Zhang FX
OncoTargets and Therapy 2016, 9:863-868
Published Date: 22 February 2016
Potential impact of 18FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus
Liu S, Zhu H, Li W, Zhang B, Ma L, Guo Z, Huang Y, Song P, Yu J, Guo H
OncoTargets and Therapy 2016, 9:855-862
Published Date: 22 February 2016
Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system review
Xu XL, Dan L, Chen W, Zhu SM, Mao WM
OncoTargets and Therapy 2016, 9:845-853
Published Date: 22 February 2016
The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations
Zheng DF, Wang R, Zhang Y, Pan YJ, Cheng XH, Cheng C, Zheng SB, Li H, Gong RX, Li Y, Shen XX, Sun YH, Chen HQ
OncoTargets and Therapy 2016, 9:833-843
Published Date: 22 February 2016
Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer
Jing X, Meng X, Sun X, Yu J
OncoTargets and Therapy 2016, 9:823-831
Published Date: 19 February 2016
Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis
Xu T, Zong YY, Peng LP, Kong S, Zhou ML, Zou JQ, Liu JL, Miao RZ, Sun XC, Li LP
OncoTargets and Therapy 2016, 9:815-822
Published Date: 19 February 2016
Association of polymorphisms in WWOX gene with risk and outcome of osteosarcoma in a sample of the young Chinese population
Zhang N, Jiang Z, Ren W, Yuan L, Zhu Y
OncoTargets and Therapy 2016, 9:807-813
Published Date: 19 February 2016
Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia
Wu YJ, Wang H, Liang JH, Miao Y, Liu L, Qiu HR, Qiao C, Wang R, Li JY
OncoTargets and Therapy 2016, 9:797-805
Published Date: 18 February 2016
PBOV1 promotes prostate cancer proliferation by promoting G1/S transition
Pan TJ, Wu RP, Liu B, Wen HD, Tu Z, Guo J, Yang JR, Shen GQ
OncoTargets and Therapy 2016, 9:787-795
Published Date: 16 February 2016
Comparative analyses of postoperative complications and prognosis of different surgical procedures in stage II endometrial carcinoma treatment
Yin H, Gui T
OncoTargets and Therapy 2016, 9:781-786
Published Date: 16 February 2016
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
Kaseb AO, Morris JS, Iwasaki M, Al-Shamsi HO, Raghav KP, Girard L, Cheung S, Nguyen V, Elsayes KM, Xiao L, Abdel-Wahab R, Shalaby AS, Hassan M, Hassabo HM, Wolff RA, Yao JC
OncoTargets and Therapy 2016, 9:773-780
Published Date: 15 February 2016
Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics
Yang F, Lyu SX, Dong SY, Liu YH, Zhang XH, Wang OC
OncoTargets and Therapy 2016, 9:761-772
Published Date: 12 February 2016
Association of polymorphisms hOGG1 rs1052133 and hMUTYH rs3219472 with risk of nasopharyngeal carcinoma in a Chinese population
Xie Y, Wu Y, Zhou X, Yao M, Ning S, Wei Z
OncoTargets and Therapy 2016, 9:755-760
Published Date: 12 February 2016
Effects of electromagnetic radiation exposure on bone mineral density, thyroid, and oxidative stress index in electrical workers
Kunt H, Şentürk İ, Gönül Y, Korkmaz M, Ahsen A, Hazman Ö, Bal A, Genç A, Songur A
OncoTargets and Therapy 2016, 9:745-754
Published Date: 12 February 2016
Primary renal carcinoid tumor: case report and review of the literature
Li B, Cui TY, Ban ZQ, Luo L, Sun LJ
OncoTargets and Therapy 2016, 9:741-743
Published Date: 23 February 2016
Monitoring cancer stem cells: insights into clinical oncology
Lin SC, Xu YC, Gan ZH, Han K, Hu HY, Yao Y, Huang MZ, Min DL
OncoTargets and Therapy 2016, 9:731-740
Published Date: 11 February 2016
Values of 99mTc-methoxyisobutylisonitrile imaging after first-time large-dose 131I therapy in treating differentiated thyroid cancer
Pan X, Duan D, Zhu Y, Pang H, Guan L, Lv Z
OncoTargets and Therapy 2016, 9:723-730
Published Date: 10 February 2016
Higher expression levels of the HOXA9 gene, closely associated with MLL-PTD and EZH2 mutations, predict inferior outcome in acute myeloid leukemia
Gao L, Sun J, Liu F, Zhang H, Ma Y
OncoTargets and Therapy 2016, 9:711-722
Published Date: 9 February 2016
Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight
Peddi P, Paryani B, Takalkar A, Bundrick P, Ponugupati J, Nair B, El-Osta H
OncoTargets and Therapy 2016, 9:705-709
Published Date: 9 February 2016
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
Kotteas EA, Syrigos KN, Saif MW
OncoTargets and Therapy 2016, 9:699-704
Published Date: 9 February 2016
Long noncoding RNAs in gastric cancer: functions and clinical applications
Wang J, Sun J, Wang J, Song Y, Gao P, Shi J, Chen P, Wang Z
OncoTargets and Therapy 2016, 9:681-697
Published Date: 10 February 2016
Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation
Liu J, Xing L, Meng X, Yue J, Meng X, Xie P, Li X, Kong L, Yu J
OncoTargets and Therapy 2016, 9:671-679
Published Date: 5 February 2016
Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review
Jeong S, Kim JH, Kim MG, Han N, Kim IW, Kim T, Oh JM
OncoTargets and Therapy 2016, 9:655-669
Published Date: 9 February 2016
Effect of tumor size on prognosis of node-negative lung cancer with sufficient lymph node examination and no disease extension
Zhang Y, Sun Y, Chen H
OncoTargets and Therapy 2016, 9:649-653
Published Date: 5 February 2016
Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report
Ji GH, Hong L, Yang P
OncoTargets and Therapy 2016, 9:643-647
Published Date: 5 February 2016
Radix Tetrastigma hemsleyani flavone inhibits proliferation, migration, and invasion of human lung carcinoma A549 cells
Zhong LR, Zheng JX, Sun QQ, Wei KM, Hu YJ
OncoTargets and Therapy 2016, 9:635-641
Published Date: 4 February 2016
Potassium-3-beta-hydroxy-20-oxopregn-5-en-17-alpha-yl sulfate: a novel inhibitor of 78 kDa glucose-regulated protein
Mhaidat NM, Al-Balas QA, Alzoubi KH, AlEjielat RF
OncoTargets and Therapy 2016, 9:627-634
Published Date: 3 February 2016
Intracellular calcium is a target of modulation of apoptosis in MCF-7 cells in the presence of IgA adsorbed to polyethylene glycol
Honorio-França AC, Nunes GT, Fagundes DLG, Marchi PGF, Fernandes RTS, França JL, França-Botelho AC, Moraes LCA, Varotti FP, França EL
OncoTargets and Therapy 2016, 9:617-626
Published Date: 3 February 2016
Retraction
Gu J, Sun R, Shen S, Yu Z
OncoTargets and Therapy 2016, 9:615-616
Published Date: 4 February 2016
Retraction
Li JZ, Zhang Y, Wen B, Li M, Wang YJ
OncoTargets and Therapy 2016, 9:613-614
Published Date: 4 February 2016
Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
Zhang Y, Xie LG, Chen T, Xie WQ, Wu ZL, Xu H, Xing C, Sha N, Shen ZH, Qie YK, Liu XT, Hu HL, Wu CL
OncoTargets and Therapy 2016, 9:605-611
Published Date: 28 January 2016
Advances in dosimetry and biological predictors of radiation-induced esophagitis
Yu Y, Guan H, Dong Y, Xing L, Li X
OncoTargets and Therapy 2016, 9:597-603
Published Date: 28 January 2016
Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients
Wang H, Wang L, Lu Y, Chen XQ, Geng QR, Wang WD, Xia ZJ
OncoTargets and Therapy 2016, 9:587-595
Published Date: 28 January 2016
Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis
Liu N, Fei X, Shen Y, Shi W, Ma J
OncoTargets and Therapy 2016, 9:579-586
Published Date: 28 January 2016
Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis
Zhang K, Zhang L, Zhou J, Hao Z, Fan S, Yang C, Liang C
OncoTargets and Therapy 2016, 9:567-577
Published Date: 27 January 2016
Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRAS
Liu J, Hu J, Cheng L, Ren W, Yang M, Liu B, Xie L, Qian X
OncoTargets and Therapy 2016, 9:557-565
Published Date: 27 January 2016
Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma
Lei ZG, Ren XH, Wang SS, Liang XH, Tang YL
OncoTargets and Therapy 2016, 9:545-555
Published Date: 27 January 2016
Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review
Sopracordevole F, Di Giuseppe J, Cervo S, Buttignol M, Giorda G, Ciavattini A, Canzonieri V
OncoTargets and Therapy 2016, 9:539-544
Published Date: 27 January 2016
Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine
Wittke S, Baxmann S, Fahlenkamp D, Kiessig ST
OncoTargets and Therapy 2016, 9:523-537
Published Date: 27 January 2016
Oct-4 is associated with gastric cancer progression and prognosis
Jiang WL, Zhang PF, Li GF, Dong JH, Wang XS, Wang YY
OncoTargets and Therapy 2016, 9:517-522
Published Date: 27 January 2016
Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors
Kitano H, Mamiya A, Ishikawa T, Egoshi K, Kokubun S, Hidai C
OncoTargets and Therapy 2016, 9:503-516
Published Date: 25 January 2016
PD-1/PD-L1 blockades in non-small-cell lung cancer therapy
Jing W, Li MM, Zhang Y, Teng FF, Han AQ, Kong L, Zhu H
OncoTargets and Therapy 2016, 9:489-502
Published Date: 25 January 2016
Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer
Shao W, Wang Q, Wang F, Jiang Y, Xu M, Xu J
OncoTargets and Therapy 2016, 9:477-487
Published Date: 25 January 2016
Utility of blood procalcitonin concentration in the management of cancer patients with infections
Durnaś B, Wątek M, Wollny T, Niemirowicz K, Marzec M, Bucki R, Góźdź S
OncoTargets and Therapy 2016, 9:469-475
Published Date: 22 January 2016
Monitoring of high-density lipoprotein cholesterol level is predictive of EGFR mutation and efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma
Lv Y, Miao LY, Chen QF, Li Y, Shi ZX, Ding XS
OncoTargets and Therapy 2016, 9:461-468
Published Date: 22 January 2016
Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis
Tang WW, Huang CW, Tang CY, Xu J, Wang HJ
OncoTargets and Therapy 2016, 9:455-460
Published Date: 22 January 2016
Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer
Ma B, Wang J, Song Y, Gao P, Sun J, Chen X, Yang Y, Wang Z
OncoTargets and Therapy 2016, 9:445-453
Published Date: 21 January 2016
Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
Xu HX, Tian YJ, Yuan X, Liu Y, Wu H, Liu Q, Wu GS, Wu KM
OncoTargets and Therapy 2016, 9:431-444
Published Date: 21 January 2016
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab
Laurenti L, Innocenti I, Autore F, Sica S, Efremov DG
OncoTargets and Therapy 2016, 9:421-429
Published Date: 20 January 2016
TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway
Wang Y, Gan Y, Tan Z, Zhou J, Kitazawa R, Jiang X, Tang Y, Yang J
OncoTargets and Therapy 2016, 9:409-420
Published Date: 20 January 2016
Efficacy and safety of ultrasound-guided continuous hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites: a midterm study of 36 patients
Wu YB, Pan MX, Cui SZ, Ba MC, Chen ZL, Ruan Q
OncoTargets and Therapy 2016, 9:403-407
Published Date: 20 January 2016
Polymorphisms in pre-miRNA genes and cooking oil fume exposure as well as their interaction on the risk of lung cancer in a Chinese nonsmoking female population
Yin Z, Li H, Cui Z, Ren Y, Li X, Wu W, Guan P, Qian B, Rothman N, Lan Q, Zhou B
OncoTargets and Therapy 2016, 9:395-401
Published Date: 19 January 2016
Expression and prognostic significance of contactin 1 in human hepatocellular carcinoma
Li GY, Huang M, Pan TT, Jia WD
OncoTargets and Therapy 2016, 9:387-394
Published Date: 19 January 2016
High levels of EGFR expression in tumor stroma are associated with aggressive clinical features in epithelial ovarian cancer
Wang K, Li D, Sun L
OncoTargets and Therapy 2016, 9:377-386
Published Date: 19 January 2016
Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis
Meng YC, Zhang CL, Zhou XH
OncoTargets and Therapy 2016, 9:367-376
Published Date: 19 January 2016
Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations
Zhang R, Li Y, Nie X, Dong X, Wu G
OncoTargets and Therapy 2016, 9:355-366
Published Date: 18 January 2016
Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
Chai YL, Wang J, Wang T, Shi F, Wang JQ, Su J, Yang YY, Zhou X, Ma HL, He B, Liu Z
OncoTargets and Therapy 2016, 9:349-354
Published Date: 19 January 2016
Functional divergence and convergence between the transcript network and gene network in lung adenocarcinoma
Hsu MK, Pan CL, Chen FC
OncoTargets and Therapy 2016, 9:335-347
Published Date: 14 January 2016
Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in hepatocellular carcinoma
Deng L, Yang J, Chen H, Ma B, Pan K, Su C, Xu F, Zhang J
OncoTargets and Therapy 2016, 9:325-333
Published Date: 14 January 2016
Single sternal metastasis due to malignant melanoma with unexpected long-term survival: a case report
Gogakos AS, Paliouras D, Asteriou C, Rallis T, Lazopoulos A, Chatzinikolaou F, Zissimopoulos A, Tsavlis D, Tsirgogianni K, Zarogoulidis K, Porpodis K, Tsakiridis K, Pitsiou G, Kioumis I, Karapantzos I, Karapantzou C, Sachpekidis N, Zarogoulidis P, Barbetakis N
OncoTargets and Therapy 2016, 9:321-323
Published Date: 18 January 2016
Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme
Hou AW, Zhao LZ, Zhao FZ, Wang WL, Niu JY, Li BX, Zhou ZJ, Zhu DY
OncoTargets and Therapy 2016, 9:315-320
Published Date: 13 January 2016
MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells
Ruan WD, Wang P, Feng S, Xue Y, Zhang B
OncoTargets and Therapy 2016, 9:303-313
Published Date: 18 January 2016
The amplification of 1q21 is an adverse prognostic factor in patients with multiple myeloma in a Chinese population
Yu W, Guo R, Qu X, Qiu H, Li J, Zhang R, Chen L
OncoTargets and Therapy 2016, 9:295-302
Published Date: 12 January 2016
WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis
Lu Y, Wang X, Sun X, Feng W, Guo H, Tang C, Deng A, Bao Y
OncoTargets and Therapy 2016, 9:287-293
Published Date: 12 January 2016
Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer
Wu Y, Li G, He D, Yang F, He G, He L, Zhang H, Deng Y, Fan M, Shen L, Zhou D, Zhang Z
OncoTargets and Therapy 2016, 9:279-286
Published Date: 11 January 2016
Polymorphisms in RAD51 and their relation with breast cancer in Saudi females
Tulbah S, Alabdulkarim H, Alanazi M, Parine NR, Shaik J, Pathan AA, Al-Amri A, Khan W, Warsy A
OncoTargets and Therapy 2016, 9:269-277
Published Date: 11 January 2016
ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy
Tian C, Yu Y, Yang HL, Zhu L, Wang YF, Zhang YZ
OncoTargets and Therapy 2016, 9:265-268
Published Date: 11 January 2016
The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro
Pu F, Chen F, Lin S, Chen S, Zhang Z, Wang B, Shao Z
OncoTargets and Therapy 2016, 9:255-263
Published Date: 11 January 2016
Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment
Franco-Molina MA, Miranda-Hernández DF, Mendoza-Gamboa E, Zapata-Benavides P, Coronado-Cerda EE, Sierra-Rivera CA, Saavedra-Alonso S, Taméz-Guerra RS, Rodríguez-Padilla C
OncoTargets and Therapy 2016, 9:243-253
Published Date: 12 January 2016
Overexpression of p53 activated by small activating RNA suppresses the growth of human prostate cancer cells
Ge Q, Wang C, Ruan Y, Chen Z, Liu J, Ye Z
OncoTargets and Therapy 2016, 9:231-241
Published Date: 8 January 2016
Association between polymorphisms in selected inflammatory response genes and the risk of prostate cancer
Chen J, Ying XM, Huang XM, Huang P, Yan SC
OncoTargets and Therapy 2016, 9:223-229
Published Date: 11 January 2016
Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients
Iliev R, Stanik M, Fedorko M, Poprach A, Vychytilova-Faltejskova P, Slaba K, Svoboda M, Fabian P, Pacik D, Dolezel J, Slaby O
OncoTargets and Therapy 2016, 9:217-222
Published Date: 8 January 2016
Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor
Wang WX, Jiang XW, Song ZB, Zhang YP
OncoTargets and Therapy 2016, 9:211-215
Published Date: 8 January 2016
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
Massacesi C, Di Tomaso E, Urban P, Germa C, Quadt C, Trandafir L, Aimone P, Fretault N, Dharan B, Tavorath R, Hirawat S
OncoTargets and Therapy 2016, 9:203-210
Published Date: 7 January 2016
Bioinformatics analysis of hepatitis C virus genotype 2a-induced human hepatocellular carcinoma in Huh7 cells
Xu P, Wu M, Chen H, Xu J, Wu M, Li M, Qian F, Xu J
OncoTargets and Therapy 2016, 9:191-202
Published Date: 8 January 2016
Expression and clinical significance of Nectin-4 in hepatocellular carcinoma
Ma J, Sheng ZY, Lv Y, Liu WB, Yao QY, Pan TT, Xu ZJ, Zhang CH, Xu GL
OncoTargets and Therapy 2016, 9:183-190
Published Date: 6 January 2016
The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis
Xie FJ, Lu HY, Zheng QQ, Qin J, Gao Y, Zhang YP, Hu X, Mao WM
OncoTargets and Therapy 2016, 9:171-181
Published Date: 6 January 2016
The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials
Yu HL, Gu DY, He X, Gao XS, Bian XH
OncoTargets and Therapy 2016, 9:159-170
Published Date: 5 January 2016
Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review
Cao Y, Zhu LZ, Jiang MJ, Yuan Y
OncoTargets and Therapy 2016, 9:149-158
Published Date: 31 December 2015
Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients
Li Z, Ma YY, Wang J, Zeng XF, Li R, Kang W, Hao XK
OncoTargets and Therapy 2016, 9:139-148
Published Date: 31 December 2015
Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features
Cao B, Wei P, Liu Z, Bi R, Lu Y, Zhang L, Zhang J, Yang Y, Shen C, Du X, Zhou X
OncoTargets and Therapy 2016, 9:131-138
Published Date: 31 December 2015
Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma
Zhang ZG, Zhang YY, Wang YY, Xu LL, Xu WJ
OncoTargets and Therapy 2016, 9:123-129
Published Date: 31 December 2015
High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy
Wang CY, Fu XL, Cai XW, Wu XH, Hu XC, Fan M, Xiang JQ, Zhang YW, Chen HQ, Jiang GL, Zhao KL
OncoTargets and Therapy 2016, 9:117-122
Published Date: 30 December 2015
Dairy consumption and lung cancer risk: a meta-analysis of prospective cohort studies
Yu Y, Li H, Xu K, Li X, Hu C, Wei H, Zeng X, Jing X
OncoTargets and Therapy 2016, 9:111-116
Published Date: 30 December 2015
MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1
Lu Y, Hu JJ, Sun W, Li S, Deng S, Li M
OncoTargets and Therapy 2016, 9:99-109
Published Date: 30 December 2015
Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis
Liu JW, He CY, Yuan Q, Wang ZN, Xing CZ, Yuan Y
OncoTargets and Therapy 2016, 9:87-97
Published Date: 30 December 2015
Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer
Patel SB, Gill D, Garrido-Laguna I
OncoTargets and Therapy 2016, 9:75-86
Published Date: 30 December 2015
Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry
Zhou J, Sun JY, Chen SY, Li FY, Lin HX, Wu SG, He ZY
OncoTargets and Therapy 2016, 9:67-73
Published Date: 23 December 2015
Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men
Zhang G, Zhu Y, Liu F, Gu CY, Chen H, Xu JF, Ye DW
OncoTargets and Therapy 2016, 9:61-66
Published Date: 22 December 2015
Low concentrations of 5-aza-2'-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression
Phan NLC, Trinh NV, Pham PV
OncoTargets and Therapy 2016, 9:49-59
Published Date: 23 December 2015
Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis
Teng JJ, Zhang J, Zhang TY, Zhang S, Li BS
OncoTargets and Therapy 2016, 9:37-47
Published Date: 21 December 2015
Expression of interleukin 1β in gastric cancer tissue and its effects on gastric cancer
Yin S, Lan C, Pei H, Zhu Z
OncoTargets and Therapy 2016, 9:31-35
Published Date: 21 December 2015
Dendrobium candidum inhibits MCF-7 cells proliferation by inducing cell cycle arrest at G2/M phase and regulating key biomarkers
Sun J, Guo Y, Fu XQ, Wang YS, Liu Y, Huo B, Sheng J, Hu X
OncoTargets and Therapy 2016, 9:21-30
Published Date: 21 December 2015
Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer
Gao Y, Song PP, Li H, Guo HB, Jia H, Zhang BJ
OncoTargets and Therapy 2016, 9:13-20
Published Date: 18 December 2015
Clinical efficacy of computed tomography-guided iodine-125 seed implantation therapy in patients with advanced spinal metastatic tumors
Zhang LY, Lu J, Wang ZM, Cheng YS, Teng GJ, Chen KM
OncoTargets and Therapy 2016, 9:7-12
Published Date: 18 December 2015
Association between an insertion/deletion polymorphism in IL-1A gene and cancer risk: a meta-analysis
Ma L, Zhou N
OncoTargets and Therapy 2016, 9:1-6
Published Date: 18 December 2015